
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Research on inner membrane complex protein 1: a novel nanovaccines against Toxoplasma gondii - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15251EB78AEF4193051EB70025A8C582.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="bmcvetres">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374472/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="BMC Veterinary Research">
<meta name="citation_title" content="Research on inner membrane complex protein 1: a novel nanovaccines against Toxoplasma gondii">
<meta name="citation_author" content="YunNan Fang">
<meta name="citation_author_institution" content="School of Animal Science and Technology, Ningxia University, Yinchuan, Ningxia PR China">
<meta name="citation_author" content="Pan Zhou">
<meta name="citation_author_institution" content="School of Animal Science and Technology, Ningxia University, Yinchuan, Ningxia PR China">
<meta name="citation_author" content="WeiYu Qi">
<meta name="citation_author_institution" content="School of Animal Science and Technology, Ningxia University, Yinchuan, Ningxia PR China">
<meta name="citation_author" content="YanLi Yu">
<meta name="citation_author_institution" content="School of economics and management, Ningxia University, Yinchuan, Ningxia PR China">
<meta name="citation_author" content="XiaoJuan Wang">
<meta name="citation_author_institution" content="School of Animal Science and Technology, Ningxia University, Yinchuan, Ningxia PR China">
<meta name="citation_author" content="YuChen Jiang">
<meta name="citation_author_institution" content="School of Animal Science and Technology, Ningxia University, Yinchuan, Ningxia PR China">
<meta name="citation_author" content="Li Zhang">
<meta name="citation_author_institution" content="School of Animal Science and Technology, Ningxia University, Yinchuan, Ningxia PR China">
<meta name="citation_author" content="YouLi Yu">
<meta name="citation_author_institution" content="Institute of Animal Science, Ningxia Academy of Agricultural and Forestry Science, Yinchuan, PR China">
<meta name="citation_author" content="JianDong Wang">
<meta name="citation_author_institution" content="Institute of Animal Science, Ningxia Academy of Agricultural and Forestry Science, Yinchuan, PR China">
<meta name="citation_author" content="ZhengQing Yu">
<meta name="citation_author_institution" content="School of Animal Science and Technology, Ningxia University, Yinchuan, Ningxia PR China">
<meta name="citation_author" content="TingLi Liu">
<meta name="citation_author_institution" content="Department of Medical Laboratory, Fenyang College of Shanxi Medical University, Fenyang, China">
<meta name="citation_publication_date" content="2025 Aug 23">
<meta name="citation_volume" content="21">
<meta name="citation_firstpage" content="521">
<meta name="citation_doi" content="10.1186/s12917-025-04961-z">
<meta name="citation_pmid" content="40849645">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374472/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374472/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374472/pdf/12917_2025_Article_4961.pdf">
<meta name="description" content="Toxoplasma gondii (T. gondii) is a globally prevalent zoonotic parasite causing severe health and economic impacts. Despite decades of research, no commercial vaccine provides comprehensive protection against both acute and chronic toxoplasmosis. ...">
<meta name="og:title" content="Research on inner membrane complex protein 1: a novel nanovaccines against Toxoplasma gondii">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Toxoplasma gondii (T. gondii) is a globally prevalent zoonotic parasite causing severe health and economic impacts. Despite decades of research, no commercial vaccine provides comprehensive protection against both acute and chronic toxoplasmosis. ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374472/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12374472">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12917-025-04961-z"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12917_2025_Article_4961.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374472%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12374472/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12374472/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374472/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-bmcvetres.png" alt="BMC Veterinary Research logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to BMC Veterinary Research" title="Link to BMC Veterinary Research" shape="default" href="https://bmcvetres.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">BMC Vet Res</button></div>. 2025 Aug 23;21:521. doi: <a href="https://doi.org/10.1186/s12917-025-04961-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12917-025-04961-z</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22BMC%20Vet%20Res%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22BMC%20Vet%20Res%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22BMC%20Vet%20Res%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22BMC%20Vet%20Res%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Research on inner membrane complex protein 1: a novel nanovaccines against <em>Toxoplasma gondii</em>
</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">YunNan Fang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">YunNan Fang</span></h3>
<div class="p">
<sup>1</sup>School of Animal Science and Technology, Ningxia University, Yinchuan, Ningxia PR China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">YunNan Fang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Pan Zhou</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Pan Zhou</span></h3>
<div class="p">
<sup>1</sup>School of Animal Science and Technology, Ningxia University, Yinchuan, Ningxia PR China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhou%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Pan Zhou</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qi%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">WeiYu Qi</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">WeiYu Qi</span></h3>
<div class="p">
<sup>1</sup>School of Animal Science and Technology, Ningxia University, Yinchuan, Ningxia PR China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qi%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">WeiYu Qi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">YanLi Yu</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">YanLi Yu</span></h3>
<div class="p">
<sup>3</sup>School of economics and management, Ningxia University, Yinchuan, Ningxia PR China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">YanLi Yu</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">XiaoJuan Wang</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">XiaoJuan Wang</span></h3>
<div class="p">
<sup>1</sup>School of Animal Science and Technology, Ningxia University, Yinchuan, Ningxia PR China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">XiaoJuan Wang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">YuChen Jiang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">YuChen Jiang</span></h3>
<div class="p">
<sup>1</sup>School of Animal Science and Technology, Ningxia University, Yinchuan, Ningxia PR China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">YuChen Jiang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Li Zhang</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Li Zhang</span></h3>
<div class="p">
<sup>1</sup>School of Animal Science and Technology, Ningxia University, Yinchuan, Ningxia PR China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Li Zhang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">YouLi Yu</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">YouLi Yu</span></h3>
<div class="p">
<sup>4</sup>Institute of Animal Science, Ningxia Academy of Agricultural and Forestry Science, Yinchuan, PR China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">YouLi Yu</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">JianDong Wang</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">JianDong Wang</span></h3>
<div class="p">
<sup>4</sup>Institute of Animal Science, Ningxia Academy of Agricultural and Forestry Science, Yinchuan, PR China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">JianDong Wang</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">ZhengQing Yu</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">ZhengQing Yu</span></h3>
<div class="p">
<sup>1</sup>School of Animal Science and Technology, Ningxia University, Yinchuan, Ningxia PR China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">ZhengQing Yu</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">TingLi Liu</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">TingLi Liu</span></h3>
<div class="p">
<sup>2</sup>Department of Medical Laboratory, Fenyang College of Shanxi Medical University, Fenyang, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">TingLi Liu</span></a>
</div>
</div>
<sup>2,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>School of Animal Science and Technology, Ningxia University, Yinchuan, Ningxia PR China </div>
<div id="Aff2">
<sup>2</sup>Department of Medical Laboratory, Fenyang College of Shanxi Medical University, Fenyang, China </div>
<div id="Aff3">
<sup>3</sup>School of economics and management, Ningxia University, Yinchuan, Ningxia PR China </div>
<div id="Aff4">
<sup>4</sup>Institute of Animal Science, Ningxia Academy of Agricultural and Forestry Science, Yinchuan, PR China </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 24; Accepted 2025 Jul 24; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12374472  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40849645/" class="usa-link">40849645</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1"><em>Toxoplasma gondii</em> (<em>T. gondii</em>) is a globally prevalent zoonotic parasite causing severe health and economic impacts. Despite decades of research, no commercial vaccine provides comprehensive protection against both acute and chronic toxoplasmosis. DNA vaccines represent a promising strategy, but their application is hindered by low delivery efficiency and limited immunogenicity. Here, we developed and evaluated pVAX1-TgIMC1-loaded PLGA and chitosan (CS) nanospheres as potential vaccine candidates. Immunization studies in mice showed that pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS nanospheres induced robust humoral and cellular immune responses, significantly enhancing specific IgG levels and cytokine production IFN-γ and IL-17 compared to the naked DNA vaccine. Both nanospheres also promoted dendritic cell maturation and T-cell activation, resulting in reduced parasite burdens in cardiac tissues post-challenge. Notably, the PLGA nanospheres exhibited superior protection against acute toxoplasmosis, while CS nanospheres provided additional advantages in antigen stability and delivery. The nanospheres were non-toxic, as confirmed by biochemical markers and histopathological analysis. These findings highlight pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS nanospheres as promising candidates for <em>T. gondii</em> vaccine development, warranting further optimization and validation in broader animal models.</p>
<section id="sec1"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s12917-025-04961-z.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> <em>Toxoplasma gondii</em>, Inner membrane complex 1, Nanomaterial nanospheres, Immunoprotection</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">Widely distributed globally, <em>Toxoplasma gondii</em> (<em>T. gondii</em>) is an obligate intracellular protozoan parasite that could infect nearly all warm-blooded mammals, including humans [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. It is estimated that approximately 30% of the global population have been infected with this parasite [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Transmission often occurs through multiple routes, including consumption of undercooked meat containing <em>T. gondii</em> tissue cysts or ingestion of food and water contaminated with cat feces, posing serious threats to public health and food safety [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. In immunocompetent individuals, infections are often asymptomatic, but immunocompromised individuals and fetuses are at risk of severe health complications, including encephalitis and congenital defects [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>–<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. The impact of <em>T. gondii</em> infection on livestock is similarly concerning. Infected animals often experience reproductive disorders, such as abortion, stillbirth, and the birth of weak offspring, leading to significant losses in production efficiency [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Moreover, infected animals may exhibit symptoms such as weakness, anorexia, and behavioral changes. Severe cases can lead to systemic inflammation, multi-organ failure, or death, particularly in young or immunocompromised animals. These issues are especially pronounced in economically significant species like sheep and pigs, further exacerbating economic burdens and posing challenges to livestock industries [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>].</p>
<p id="Par3">To date, no effective strategy for the complete eradication of <em>T. gondii</em> infection has been achieved. Current treatment options, including sulfonamides and folate antagonists, are associated with significant side effects and cannot eliminate tissue cyst-residing bradyzoites [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. Vaccines remain the most effective approach for preventing toxoplasmosis. However, the only commercially available vaccine, Toxovax<sup>®</sup> (Ovilis Toxovax<sup>®</sup>), is approved solely for preventing abortion in sheep [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. Moreover, its efficacy against tissue cyst formation is debated, and it lacks applicability to other host species and livestock. Developing a safe, effective, and broadly protective vaccine against <em>T. gondii</em> has thus become a pressing scientific and public health challenge to reduce infection rates and economic losses. For this study, we constructed a DNA vaccine using the pVAX1 plasmid vector to express the <em>Toxoplasma gondii</em> IMC1 protein (TgIMC1). The resulting plasmid construct is designated as pVAX1-TgIMC1, which encodes and expresses the recombinant TgIMC1 protein (rTgIMC1) in host cells.</p>
<p id="Par4">In recent years, various candidate vaccines have been explored, including live-attenuated vaccines, subunit vaccines, DNA vaccines, and recombinant protein vaccines [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. Among these, live attenuated vaccines offer strong immunogenicity but carry safety risks such as virulence reversion [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. Subunit vaccines, while safer, often lack sufficient immunogenicity and rely heavily on adjuvants [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. In contrast, DNA vaccines can simultaneously induce both humoral and cellular immune responses, significantly enhancing overall immunological efficacy [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. They also allow rapid adaptation to new pathogens or mutations and avoid immune interference from viral vectors [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. With advantages such as high safety, stability, short production cycles, and low cost, DNA vaccines have garnered significant attention in modern vaccine development. At the same time, selecting the right vaccine antigen is crucial. The <em>Toxoplasma gondii</em> IMC1 protein is a key component of the substructure within the inner membrane complex (IMC), known as alveolin, which primarily provides mechanical support and maintains parasite morphological stability during the formation of daughter parasites [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. In its immature stage, IMC1 exhibits high solubility in detergents such as deoxycholate. However, as the daughter cells mature, approximately 5 kDa of the C-terminus is cleaved by specific proteases, transitioning the protein from a soluble state into a detergent-insoluble, robust network structure [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. This transformation enables IMC1 to provide enhanced stability and mechanical support during sporozoite maturation and is closely associated with anchoring the parasite’s motility apparatus, such as the actin-myosin motor complex, ensuring <em>T. gondii</em>’s ability to grow and invade within and outside host cells [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. Given its critical function, TgIMC1 is expected to be a candidate antigen for <em>T. gondii</em> vaccine development. Therefore, we constructed a DNA vaccine plasmid (pVAX1-TgIMC1) encoding this protein.</p>
<p id="Par5">Polylactic-co-glycolic acid (PLGA) and chitosan (CS) are two widely utilized biodegradable materials with distinct yet complementary advantages in immunological applications. PLGA effectively protects antigens from environmental degradation, maintaining their stability and bioactivity. Its controlled degradation rate enables sustained release and precise delivery, prolonging immune stimulation and enhancing immune responses [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>, <a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. Similarly, CS, derived from the natural polysaccharide chitin, offers excellent biocompatibility and biodegradability. Its cationic properties facilitate interactions with cell membranes and mucosal surfaces, increasing antigen retention and boosting immune response intensity. Additionally, CS enhances antigen uptake and activation by dendritic cells and macrophages, promotes cytokine secretion, and supports immune cell maturation. Together, these properties position PLGA and CS as promising materials for advanced vaccine delivery systems, capable of improving antigen stability, delivery efficiency, and immunogenicity [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>, <a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>].</p>
<p id="Par6">In this study, a novel nanoparticle-based DNA vaccine was constructed using the pVAX1-TgIMC1 plasmid construct encoding the TgIMC1 protein to prevent and control toxoplasmosis. Recombinant TgIMC1 protein (rTgIMC1) was expressed in a prokaryotic system and the pVAX1-TgIMC1 plasmid construct was encapsulated in PLGA and CS nanoparticles to develop the vaccine formulations. Following a specific immunization protocol, pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS nanoparticles were administered to mice. Subsequently, spleens of immunized mice were collected for histological analysis, and antibody levels, cytokine profiles, lymphocyte proliferation, and cardiac parasite burden were measured. The immunoprotective efficacy of the nanoparticle vaccine was evaluated based on these experimental findings.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<p id="Par7">Our approach involves: (1) construction of the pVAX1-TgIMC1 DNA vaccine plasmid, (2) expression and purification of recombinant TgIMC1 protein for characterization, and (3) encapsulation of the DNA vaccine in biodegradable nanoparticles for enhanced delivery and immunogenicity.</p>
<section id="Sec3"><h3 class="pmc_sec_title">Parasites, cells, and animals</h3>
<p id="Par8">The <em>Toxoplasma gondii</em> RH (Type I) strain was used to infect mice. The <em>Toxoplasma gondii</em> RH (Type I) strain was obtained from Dr. Xiangrui Li at Nanjing Agricultural University, China, where it was originally isolated from a human case and maintained by serial passage in mice. This strain is preserved in liquid nitrogen at the Laboratory of Veterinary Molecular and Immunological Parasitology at Ningxia University, China. Female BALB/c mice (6–8 weeks old, 18–22 g), were obtained from Beijing Vital River Laboratory Animal Technology Co., Ltd. and housed in a specific pathogen-free (SPF) barrier system with ad libitum access to food and water. To maintain the <em>T. gondii</em> RH (Type I) strain, mice were inoculated intraperitoneally twice a week. Tachyzoites were harvested from the peritoneal lavage fluid of the inoculated mice, washed by centrifugation in phosphate-buffered saline (PBS), and resuspended to a final concentration of 1 × 10<sup>8</sup> tachyzoites per ml in PBS for subsequent inoculations [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>].</p>
<p id="Par9">Human embryonic kidney 293-T cells (HEK 293-T) purchased from Shanghai Institute of Cell Biology, Chinese Academy of Sciences, containing 10% fetal bovine serum (FBS; Gibco, Carlsbad, CA, USA) and 1% double antibiotics (penicillin-streptomycin solution, Gibco, Carlsbad, CA, USA) were cultured at 37 °C in 5% CO<sub>2</sub> atmosphere.</p>
<p id="Par10">Specific pathogen-free (SPF) mice (18–22 g, including female BALB/c mice aged 6–8 weeks) and Sprague-Dawley rats (200–220 g, 8–10 weeks old) were obtained from the Animal Research Center of Charles River company and used in the study. All mice were housed under identical SPF conditions. Mice were euthanized by gradual-fill carbon dioxide asphyxiation. All the experimental design, animal management, injection, and operations were strictly followed the Ethics Procedures and Guidelines of the People’s Republic of China and were supervised by the Animal Ethics Committee, Ningxia University, Yinchuan, P.R. China. The mouse license number was NXU-2023-083, and the rat license number was NXU-2023-086.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Gene cloning and plasmid construction</h3>
<p id="Par11">To enhance the expression of the rTgIMC1 protein in animals, the TgIMC1 gene sequence (TGRH88_075820) was submitted for codon optimization using the online tool at <a href="http://www.novopro.cn/tools/codon-optimization.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.novopro.cn/tools/codon-optimization.html</a>. and the optimized species was mammal. The optimized gene sequence was then synthesized by Sangon Biotech (Shanghai, China). The obtained gene fragment was PCR-amplified using the primers IMC1-opt-MF: 5ʹ-GGTACCATGTTTAAAGATTGTGCAGACCCATGT-3ʹand IMC1-opt-MR: 5ʹ-GGATCCTTAGCACTGGCAGCGAAAAC-3ʹ. The PCR reaction setup, as per the manufacturer’s instructions (Vazyme Biotech, Nanjing, China), included 12.5 µl of 2 × Phanta Max Master Mix, 1 µl each of IMC1-opt-MF and IMC1-opt-MR primers, 500 ng of cDNA template, and ddH₂O added to a final volume of 25 µl. The cDNA template was synthesized from total RNA extracted from 10^7 <em>T. gondii</em> RH tachyzoites using reverse transcription (Takara Biotechnology, Dalian, China). The thermal cycling conditions were as follows: an initial denaturation at 95 °C for 3 min, followed by 35 cycles of denaturation at 95 °C for 15 s, annealing at 58 °C for 15 s, and extension at 72 °C for 1 min, with a final extension at 72 °C for 5 min. The PCR products were verified using 1% agarose gel electrophoresis, and the correct band was purified with a gel extraction kit (OMEGA Bio-Tek, Norcross, GA, USA). After restriction digestion with <em>Kpn</em>I and <em>Bam</em>HI (Takara Biotechnology, Dalian, China), the purified gene fragment was ligated into a linearized pVAX1 vector to create the pVAX1-TgIMC1 recombinant plasmid. The resulting plasmid was verified by double enzyme digestion and subsequently transformed into <em>E. coli</em> DH5α competent cells. Single colonies were selected and cultured to obtain genetically engineered bacteria. Following large-scale cultivation, Endotoxin-free DNA plasmids were extracted using an Endo-free DNA plasmid extraction kit (Vazyme Biotech, Nanjing, China) and verified with the ToxinSensor™ Chromogenic LAL Endotoxin Assay Kit (GeneScript, Piscataway, NJ, USA), Ensure that the obtained plasmid endotoxin is at a low level. The concentration of the obtained plasmid was determined using a Nanodrop spectrophotometer (Thermo Scientific, Waltham, MA, USA) before storage at -20 °C.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Preparation of antibodies targeting <em>T. gondii</em> soluble antigens</h3>
<p id="Par12">To obtain the soluble tachyzoite antigen (STAg) of <em>Toxoplasma gondii</em>, the collected peritoneal lavage fluid was filtered with a 5 μm filter membrane (Millipore, Billerica, MA, USA) [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. After centrifugation at 2500 rpm for 5 min, 5 × 10<sup>6</sup>
<em>T. gondii</em> RH tachyzoites were re-dissolved in 1000 µl PBS. Then protease and phosphatase inhibitors were added according to the instructions (Beyotime, Shanghai, China), tip sonication was performed in pulse mode (2 s on, 2 s off) at 30 W output power for 10 min total. The total protein concentration was determined by BCA assay (Thermo Scientific, Waltham, MA, USA) prior to storage at -20 °C.</p>
<p id="Par13">Two Sprague-Dawley rats were immunized subcutaneously with 200 µg STAg emulsified in complete Freund’s adjuvant. Two weeks later, the rats received four booster injections of 200 µg STAg emulsified in incomplete Freund’s adjuvant at weekly intervals. Each injection was administered subcutaneously at multiple dorsal sites. One week after the final immunization, blood was collected from the orbital plexus, and sera containing polyclonal antibodies against <em>T. gondii</em> STAg were obtained.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Detection of pVAX1-TgIMC1 in vitro</h3>
<p id="Par14">HEK 293-T cells were cultured in six-well plates and transfected with Endo-free pVAX1-TgIMC1 plasmid using Lipofectamine 2000 reagent (Invitrogen Biotechnology, Shanghai, China). After 48 h of transfection, the culture supernatant was discarded, and the cells were washed three times with PBS. The cells were then fixed with 1 ml of 4% paraformaldehyde at 4 °C for 12 h to maintain structural integrity, followed by permeabilization with Tris-buffered saline containing 0.1% Triton X-100 (TBSx) to increase membrane permeability and facilitate antibody entry. To minimize nonspecific binding, the cells were blocked with TBSx containing 5% bovine serum albumin (BSA). After blocking, the cells were incubated with anti-STAg serum (primary antibody, 1:100) diluted in TBSx with 5% BSA to detect the target antigen. Unbound primary antibodies were removed by washing the cells with TBSx for 5 min, and the cells were subsequently incubated with CY3-conjugated anti-rat IgG (secondary antibody, 1:1000, Sigma, Saint Louis, MO, USA) for specific labeling. To visualize nuclei, 500 µl of DAPI staining solution (Beyotime, Shanghai, China) was added to each well. Finally, images were captured and analyzed using a laser scanning confocal microscope (Nikon Corporation, Tokyo, Japan).</p>
<p id="Par15">To confirm the in vitro expression of the constructed plasmid, transfected HEK 293-T cells were incubated at 37 °C for 48 h. After incubation, the cells were lysed in RIPA lysis buffer containing protease and phosphatase inhibitors (Beyotime, Shanghai, China) and disrupted using probe sonication (Scientz Biotechnology, Ningbo, China) under the parameters described in the antibody preparation section. Following sonication, 10× SDS-PAGE loading buffer was added to the lysates, thoroughly mixed, and heated at 95 °C for 5 min to fully denature the proteins. The protein samples were then separated by electrophoresis on a 12% SDS-PAGE gel and transferred onto a PVDF membrane for Western blot analysis. Detection was performed using rat anti-TgIMC1 protein serum (1:500) as the primary antibody and goat anti-rat IgG (1:1000) as the secondary antibody. Untransfected cells were used as a negative control, and protein bands were visualized using an enhanced chemiluminescence (ECL) substrate.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Preparation of nanospheres</h3>
<p id="Par16">To synthesize PLGA nanospheres, 100 mg of PLGA (molecular weight 40,000–75,000 Da, LA/GA: 65/35, Sigma, Saint Louis, MO, USA) was dissolved in 1 ml of dichloromethane (DCM; Sigma, Saint Louis, MO, USA) in a 50 ml centrifuge tube with a magnetic stir bar. Separately, a 2% polyvinyl alcohol (PVA; MW 31,000–75,000 Da, Sigma, Saint Louis, MO, USA) solution was prepared by dissolving PVA in double-distilled water, followed by filtration through a 0.22 μm membrane (Millipore, Billerica, MA, USA). At room temperature, 2 ml of the PVA solution was stirred at 400 rpm, and 4 mg of endotoxin-free DNA plasmid (1 mg/ml) was added dropwise using a pipette. After vortexing for 5 min, the organic solution was added dropwise to the aqueous solution while stirring at 400 rpm, followed by tip sonication at 4 °C (140 W power, 2-second pulses for a total of 5 min) to form a water-in-oil (<em>w</em>/<em>o</em>) emulsion. The w/o emulsion was then added dropwise to 3 ml of 6% PVA solution under the same stirring and sonication conditions to form a water-in-oil-in-water (<em>w</em>/<em>o</em>/<em>w</em>) emulsion, which was stirred overnight at 400 rpm to evaporate the DCM. The w/o/w emulsion was centrifuged at 40,000 rpm for 50 min at 4 °C, and the resulting PLGA nanospheres (pellet) were collected, filtered through a 0.22 μm membrane, and frozen. After lyophilization in a vacuum freeze dryer (Labconco, Kansas City, MO, USA), the PLGA nanospheres were stored in a sealed container at 4 °C until further use.</p>
<p id="Par17">For the preparation of the chitosan solution, 20 mg of chitosan was dissolved in 10 ml of 1.0% acetic acid solution, and the pH was adjusted to 5.0 using 1 M NaOH solution. The chitosan solution was placed on a magnetic stirrer and maintained at 30 °C. Endo-free pVAX1-TgIMC1 plasmid (4 mg) was added dropwise, followed by 2 ml of 2 mg TPP solution, with continuous stirring for an additional 30 min after the addition. The mixture was then sonicated at 4 °C with an ultrasonic power of 140–160 W, alternating 1–2 s on and 1–2 s off, for a total duration of 4–5 min. After sonication, the mixture was centrifuged at 40,000 rpm for 15 min. The chitosan nanospheres (precipitation) were collected in double-distilled water, while the supernatant was retained for further analysis. After filtration through a 0.22 μm membrane, the collected PLGA nanoparticles were frozen. Once completely solidified, the nanoparticles were transferred to a vacuum freeze dryer and lyophilized until fully dried. The lyophilized CS nanospheres were stored under sealed conditions at -20 °C until further use.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Characterization of synthesized nanospheres</h3>
<p id="Par18">The prepared pVAX1-TgIMC1 nanoparticles were sent to the College of Life Sciences, Nanjing Agricultural University for imaging using a scanning electron microscope (SEM). Based on the SEM images, the average diameter of the pVAX1-TgIMC1 nanovaccine was analyzed using ImageJ software. To determine the encapsulation efficiency, the supernatant was collected after ultracentrifugation, and the total volume was recorded. The concentration of free protein in the supernatant was measured using the BCA assay. The loading capacity (LC) and encapsulation efficiency (EE) of PLGA and nanospheres were then calculated based on Eqs. (<a href="#Equ1" class="usa-link">1</a>) and (<a href="#Equ2" class="usa-link">2</a>), respectively.</p>
<table class="disp-formula p" id="Equ1"><tr>
<td class="formula"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522c/12374472/30d7bbbef406/d33e515.gif" loading="lazy" id="d33e515" alt="graphic file with name d33e515.gif"></td>
<td class="label">1</td>
</tr></table>
<table class="disp-formula p" id="Equ2"><tr>
<td class="formula"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522c/12374472/8ba5e17ca5c3/d33e521.gif" loading="lazy" id="d33e521" alt="graphic file with name d33e521.gif"></td>
<td class="label">2</td>
</tr></table></section><section id="Sec9"><h3 class="pmc_sec_title">Assessment of nanosphere toxicity</h3>
<p id="Par19">Thirty-five mice were randomly divided into seven groups (<em>n</em> = 5 per group) as follows: Blank group (immunized with PBS), Control group (immunized with 300 µg of empty pVAX1 plasmid), pVAX1/CS group (immunized with pVAX1/CS nanoparticles), pVAX1/PLGA group (immunized with pVAX1/PLGA nanoparticles), pVAX1-TgIMC1 group (immunized with pVAX1-TgIMC1 plasmid), pVAX1-TgIMC1/CS group (immunized with pVAX1-TgIMC1/CS nanoparticles), and pVAX1-TgIMC1/PLGA group (immunized with pVAX1-TgIMC1/PLGA nanoparticles). Each mouse received an intramuscular injection at a dose three times the standard immunization amount. Three days after the first immunization, a booster immunization was administered. Three days after the second immunization, blood was collected from the retro-orbital sinus, and serum was separated. Serum creatinine (Cr) and blood urea nitrogen (BUN) levels were measured using creatinine oxidase and urease-indophenol methods, respectively. The mental status and activity levels of the mice were monitored throughout the experiment.</p></section><section id="Sec10"><h3 class="pmc_sec_title">Immunization and challenging schedules in mice</h3>
<p id="Par20">Female mice, weighing 18–22 g, were purchased from Beijing Vital River Laboratory Animal Technology Co. and housed in an SPF barrier system with ad libitum access to food and water. The mice were randomly allocated into seven experimental groups as detailed in Table <a href="#Tab1" class="usa-link">1</a>: Blank group, Control group, pVAX1/CS group, pVAX1/PLGA group, pVAX1-TgIMC1 group, pVAX1-TgIMC1/CS group, and pVAX1-TgIMC1/PLGA group. All groups received two intramuscular injections administered at ten-day intervals through multiple injection points in the leg muscles. Pre-immunization blood samples were collected via retro-orbital bleeding to establish baseline serum parameters, which were subsequently stored at -20 °C until analysis.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Immunization strategy in mice</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Group</th>
<th align="left" colspan="1" rowspan="1">Day10 and Day20</th>
<th align="left" colspan="1" rowspan="1">Day20</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Blank</td>
<td align="left" colspan="1" rowspan="1">100 µl PBS</td>
<td align="left" rowspan="7" colspan="1">100 <em>T. gondii</em> RH tachyzoites intraperitoneally per mouse</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Control</td>
<td align="left" colspan="1" rowspan="1">100 µl pVAX1empty DNA vaccine</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CS</td>
<td align="left" colspan="1" rowspan="1">100 µl pVAX1-loaded CS nanoparticles</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PLGA</td>
<td align="left" colspan="1" rowspan="1">100 µl pVAX1-loaded PLGA nanoparticles</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">pVAX1-TgIMC1</td>
<td align="left" colspan="1" rowspan="1">100 µl pVAX1-TgIMC1 DNA vaccine</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">pVAX1-TgIMC1/CS</td>
<td align="left" colspan="1" rowspan="1">100 µl pVAX1-TgIMC1-loaded CS nanoparticles</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">pVAX1-TgIMC1/PLGA</td>
<td align="left" colspan="1" rowspan="1">100 µl pVAX1-TgIMC1-loaded PLGA nanoparticles</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec11"><h3 class="pmc_sec_title">Antibody and cytokine investigation</h3>
<p id="Par22">The levels of IgG, IgG1 and IgG2a in serum samples of mice were determined by indirect enzyme-linked immunosorbent assay (ELISA). Briefly, 96-well plates were coated overnight at 4 °C with 1 µg of soluble <em>T. gondii</em> antigen (STAg) diluted in carbonate buffer. After incubation, the plates were washed with TBS containing 0.05% Tween-20 (TBS-T) and blocked for 1 h at room temperature with 5% bovine serum albumin (BSA) in TBS-T. Following three washes with TBS-T, mouse serum samples, diluted 1:100 in TBS-T with 5% BSA, were added to the wells and incubated for 1 h. The plates were then washed three additional times with TBS-T before adding HRP-conjugated goat anti-mouse IgG, IgG1, or IgG2a antibodies (diluted 1:5000), which were incubated at 37 °C for 1 h. After a final wash, 100 µl of TMB substrate solution was added to each well for color development, and the reaction was terminated using 2 mol/L H₂SO₄. The absorbance was measured at 450 nm using a microplate reader.</p>
<p id="Par23">To evaluate cytokine levels post-boost, retro-orbital blood was collected, and serum levels of IFN-γ, TGF-β, IL-4, IL-6, IL-10, IL-17, and IL-12 were quantified using a sandwich ELISA kit (Elabscience, China).</p></section><section id="Sec12"><h3 class="pmc_sec_title">Flow cytometry analysis</h3>
<p id="Par24">On day 10 post-primary and secondary immunizations, five mice per group were euthanized by CO₂ asphyxiation, and splenocytes were isolated using commercial spleen lymphocyte separation kit (Solarbio, Beijing, China). The isolated splenocytes were cultured overnight in DMEM with 10% FBS and 1% penicillin-streptomycin. Non-adherent cells were removed the next day, and adherent cells were washed with PBS three times and collected. The cells were then stained at 4 °C in the dark for 40 min using anti-mouse CD11c-APC, CD86-FITC, and CD83-PE antibodies. Following staining, cells were washed three times with PBS and analyzed using flow cytometry.</p>
<p id="Par25">To investigate changes in CD83, CD86, and MHC molecules in splenic dendritic cells (DCs), isolated lymphocytes were subjected to dual staining. The cells were incubated with anti-mouse CD11c-APC, CD86-FITC, CD83-PE, or CD11c-PE, MHC-I-FITC, and MHC-II-APC antibodies (eBioscience, San Diego, CA, USA) at 4 °C for 40 min in the dark. After incubation, the cells were washed three times with PBS, centrifuged, and collected. The stained cells were then analyzed using flow cytometry.</p>
<p id="Par26">In the flow cytometry analysis, we employed a tiered gating strategy to address different biological questions. For total population analysis, live single cells were first selected by FSC-A/SSC-A and FSC-H/FSC-W gating, followed by identification of CD11c<sup>+</sup> cells, with percentages of CD86<sup>+</sup> or MHC II<sup>+</sup> cells calculated relative to total splenocytes to assess overall immune activation. For subset-specific analysis, we further gated on CD11c<sup>+</sup> cells with high FSC/SSC characteristics (representing mature, activated DCs) and reported percentages relative to the parent CD11c<sup>+</sup> population to evaluate DC-specific functionality. This approach allowed us to distinguish between systemic immune response magnitude and specialized DC subpopulation characteristics. All gating boundaries were established using fluorescence-minus-one (FMO) and isotype controls, with consistent gates applied across samples using the CytoExpert software (version 2.3, Beckman Coulter, Brea, CA, USA).</p></section><section id="Sec13"><h3 class="pmc_sec_title">Lymphocyte proliferation of spleen</h3>
<p id="Par27">On day 28, splenic cells were isolated from mice using the previously described method. A total of 5 × 10⁵ cells per well were seeded into 96-well plates, with each well stimulated with rTgIMC1 (10 µg/ml). The plates were incubated at 37 °C with 5% CO₂ for 48 h. Following incubation, 10 µl of CCK-8 reagent (BioTek, Burlington, VT, USA) was added to each well, and the plates were further incubated for 4 h. Optical density (OD) values were then measured at 450 nm using a microplate reader.</p></section><section id="Sec14"><h3 class="pmc_sec_title">
<em>T. gondii</em> burden in animals</h3>
<p id="Par28">Fourteen days after booster immunization, all mice were intraperitoneally challenged with 100 tachyzoites of the virulent <em>T. gondii</em> RH strain. Four days post-challenge, spleens were collected from three euthanized mice per group. Spleen tissues were fixed in formalin for 24–48 h, dehydrated with graded ethanol, cleared in xylene for 40 min, and embedded in paraffin. Using a Minux<sup>®</sup> rotary microtome S710 (RWD Life Science, Shenzhen, China), 4–6 μm sections were prepared, mounted on slides, and dried at 37 °C for 24 h. After deparaffinization and antigen retrieval with EDTA buffer, sections were treated with 3% H₂O₂ for 25 min to block endogenous peroxidase activity. The sections were then blocked with 5% bovine serum albumin at 37 °C for 30 min and incubated overnight at 4 °C with anti-<em>T. gondii</em> antibody (1:500 dilution, Abcam, Cambridge, UK). Following three washes with PBS, sections were incubated at room temperature for 1 h with CY3-conjugated goat anti-rabbit IgG (1: 1000 dilution, ABclonal, Wuhan, China). After washing with TBS, the sections were counterstained with DAPI, mounted, and examined under a fluorescence microscope to assess the distribution of <em>T. gondii</em> in the spleen tissues.</p>
<p id="Par29">To assess parasite burden, five mice per group were euthanized by CO₂ asphyxiation, and spleen tissues were collected. Genomic DNA was extracted from the tissues using a commercial kit, and parasite load in cardiac tissue was quantified by absolute quantitative PCR targeting the <em>Toxoplasma gondii</em> 529 bp repeat sequence. Plasmids containing the 529 bp sequence served as reference standards for evaluating infection intensity in cardiac tissue. Each DNA sample was tested in triplicate.</p></section></section><section id="Sec15"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec16"><h3 class="pmc_sec_title">Expression of rTgIMC1 and Western blot analysis</h3>
<p id="Par30">The pVAX1-TgIMC1 plasmid was successfully constructed in this study. To verify the plasmid, Double digestion with <em>Kpn</em>I and <em>Bam</em>HI yielded two fragments: 2,987 bp (pVAX1 vector) and 1,836 bp (optimized pVAX1-TgIMC1 insert) (Fig. <a href="#Fig1" class="usa-link">1</a>). Subsequently, the plasmid was sent to Sangon Biotech for sequencing, and the results confirmed that the inserted fragment within the plasmid is the open reading frame (ORF) of pVAX1-TgIMC1. These findings demonstrate that the pVAX1-TgIMC1 plasmid was correctly constructed.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374472_12917_2025_4961_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522c/12374472/b51b579b98fb/12917_2025_4961_Fig1_HTML.jpg" loading="lazy" id="d33e699" height="261" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong> Double digestion analysis of the recombinant plasmid pVAX1-TgIMC1. M: DL5000 marker; Lane 1: Double digestion with <em>Kpn</em>I and <em>Bam</em>HI. <strong>B</strong> Immunofluorescence analysis of pVAX1-TgIMC1 expression in HEK 293-T cells. The scale bar represents 25 μm. <strong>C</strong> Western blotting of cell lysates probed with rat polyclonal antibodies against <em>Toxoplasma gondii</em> STAg. Cell lysates of HEK 293-T cell transfected with pVAX1-TgIMC1 (Line 1) and pVAX1 (Line 2) plasmids. Line M, MW marker proteins</p></figcaption></figure><p id="Par32">The endotoxin levels in the extracted plasmid were measured using an endotoxin assay kit, with values found to be below 0.01 EU/ml. After transfecting HEK 293-T eukaryotic cells with endotoxin-free pVAX1-TgIMC1 plasmid, results are shown in Fig. <a href="#Fig1" class="usa-link">1</a>B. Cells transfected with pVAX1-TgIMC1 exhibited specific red fluorescence, whereas cells transfected with the control pVAX1 plasmid showed no red fluorescence, indicating the successful expression of the recombinant TgIMC1 protein. Western blot analysis using home-made rat anti-TgIMC1 serum revealed a single band with a molecular weight of approximately 100 kDa (Fig. <a href="#Fig1" class="usa-link">1</a>C), while no corresponding band was detected in cells transfected with the control pVAX1 plasmid. These results confirm that the recombinant TgIMC1 protein was successfully expressed via the pVAX1-TgIMC1 plasmid.</p></section><section id="Sec17"><h3 class="pmc_sec_title">Characterization of nanospheres</h3>
<p id="Par33">After encapsulating the pVAX1-TgIMC1 plasmid in PLGA and chitosan (CS) nanoparticles, the morphology of the nanoparticles was examined using SEM. SEM analysis showed that both PLGA and CS nanoparticles were spherical, with small round protrusions on their surfaces (Fig. <a href="#Fig2" class="usa-link">2</a>). Based on randomly selected SEM images of five nanoparticles, the synthesized PLGA nanoparticles had an average diameter of 68.04 ± 5.21 nm, while the synthesized CS nanoparticles had an average diameter of 84.12 ± 7.23 nm. Results from three independent experiments indicated that the loading capacity (LC) of PLGA and CS nanospheres was 0.99 ± 0.12% and 6.42 ± 0.65%, respectively, while their encapsulation efficiency (EE) was 70.18 ± 1.22% and 62.40 ± 2.02%, respectively.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374472_12917_2025_4961_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522c/12374472/cbb05785d290/12917_2025_4961_Fig2_HTML.jpg" loading="lazy" id="d33e731" height="265" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The pVAX1-TgIMC1 plasmid was encapsulated into poly (lactic-co-glycolic acid) (PLGA) (<strong>A</strong>) and chitosan (CS) (<strong>B</strong>) nanoparticles, and their morphology was observed using SEM. PLGA and CS nanoparticles were synthesized using solvent evaporation (w/o/w) and ionic gelation techniques, respectively. After complete lyophilization, the magnification was set to ×30,000, with scale bars representing 500 nm</p></figcaption></figure><p id="Par36">To study the release profiles of pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS nanoparticles, comparisons were made with blank PLGA and CS nanoparticles. As shown in Fig. <a href="#Fig3" class="usa-link">3</a>, a sharp increase in release was observed for both nanoparticles within the first two days. pVAX1-TgIMC1/CS nanoparticles exhibited a more gradual release curve compared to pVAX1-TgIMC1/PLGA nanoparticles. After day 4, the release profile of pVAX1-TgIMC1/PLGA nanoparticles stabilized, but a slow-release trend was observed for both nanoparticle types until day 5. In vitro results showed that both obtained nanospheres could provide a stable release for one week, thereby enhancing the effectiveness of immunization.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522c/12374472/ff3db024e026/12917_2025_4961_Fig3_HTML.jpg" loading="lazy" id="d33e745" height="408" width="590" alt="Fig. 3"></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The release curves of pVAX1-TgIMC1 plasmid encapsulated in PLGA and CS nanoparticles were measured in vitro over seven days. Comparisons were made with blank PLGA and CS nanoparticles. The total plasmid content in the supernatant was determined using a Nanodrop spectrophotometer. Three independent experiments were conducted, with each sample measured once. The values are presented as mean ± standard deviation (SD) (<em>n</em> = 3)</p></figcaption></figure><p id="Par37">The toxicity of PLGA and CS nanoparticles containing the pVAX1-TgIMC1 plasmid was evaluated by measuring Cr (Fig. <a href="#Fig4" class="usa-link">4</a>A) and BUN levels (Fig. <a href="#Fig4" class="usa-link">4</a>B) using the creatinine oxidase and urease-indole method. Results showed that Cr and BUN levels were within acceptable ranges, with no statistically significant differences (<em>p</em> &gt; 0.05) between experimental groups and the blank or control groups. Additionally, no abnormal changes were observed in the physical health or mental status of experimental animals during the study. These findings confirm that the synthesized nanoparticles are non-toxic.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374472_12917_2025_4961_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522c/12374472/ea6e888880ce/12917_2025_4961_Fig4_HTML.jpg" loading="lazy" id="d33e781" height="334" width="744" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The toxicity of pVAX1-TgIMC1 plasmid encapsulated in PLGA and chitosan nanoparticles was analyzed. Serum samples were collected from each group, and Cr (<strong>A</strong>) and blood urea nitrogen (BUN) (<strong>B</strong>) levels were measured according to the instructions provided with commercial kits. Each serum sample was tested once. Statistical significance was evaluated using one-way ANOVA, followed by Dunnett’s test. After Bonferroni correction, pairwise comparisons of pVAX1-TgIMC1, pVAX1-TgIMC1/PLGA, and pVAX1-TgIMC1/CS groups were performed. Results are presented as mean ± SD (<em>n</em> = 5)</p></figcaption></figure></section><section id="Sec18"><h3 class="pmc_sec_title">Antibodies determination</h3>
<p id="Par39">The immunogenicity of pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS nanoparticles was evaluated by comparing single and booster immunizations with either the pVAX1-TgIMC1 plasmid alone or the nanoparticle-encapsulated plasmid. The results demonstrated that both pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS groups induced significantly higher IgG levels after both primary and booster immunizations compared to the control group (<em>p</em> &lt; 0.001, Fig. <a href="#Fig5" class="usa-link">5</a>A). Notably, animals immunized with the naked pVAX1-TgIMC1 plasmid alone also exhibited a significant increase in total IgG levels compared to the control group (<em>p</em> &lt; 0.01), albeit lower than the nanoparticle groups. Following the primary immunization, animals immunized with pVAX1-TgIMC1/CS nanoparticles exhibited significantly higher IgG levels compared to those immunized with pVAX1-TgIMC1/PLGA nanoparticles (<em>p</em> &lt; 0.01).</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374472_12917_2025_4961_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522c/12374472/1e5355f92bd8/12917_2025_4961_Fig5_HTML.jpg" loading="lazy" id="d33e830" height="492" width="669" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The total IgG (<strong>A</strong>), IgG1 (<strong>B</strong>), and IgG2a (<strong>C</strong>) levels in the serum of immunized animals were measured at weeks 0, 2, and 4. Each serum sample was tested once. Statistical significance was evaluated using one-way ANOVA, followed by Dunnett’s test and Bonferroni correction. Pairwise comparisons of pVAX1-TgIMC1, pVAX1-TgIMC1/PLGA, and pVAX1-TgIMC1/CS groups were performed. The results are presented as OD450 ± standard deviation (SD) (<em>n</em> = 5). Significant differences compared to the blank or control groups were indicated (*<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001)</p></figcaption></figure><p id="Par41">Furthermore, as shown in Fig. <a href="#Fig5" class="usa-link">5</a>B and C, both pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS groups generated higher levels of <em>T. gondii</em>-specific IgG1 and IgG2a compared to the control and naked pVAX1-TgIMC1 plasmid groups. The naked pVAX1-TgIMC1 plasmid alone also induced detectable IgG1 and IgG2a responses (<em>p</em> &lt; 0.05 vs. control), but these were significantly surpassed by the nanoparticle formulations (<em>p</em> &lt; 0.001). Notably, regardless of the number of immunizations, pVAX1-TgIMC1/CS and pVAX1-TgIMC1/PLGA nanoparticle immunizations resulted in a statistically significant increase in IgG1 levels compared to naked rTgIMC1 protein (<em>p</em> &lt; 0.001, Fig. <a href="#Fig5" class="usa-link">5</a>B).</p></section><section id="Sec19"><h3 class="pmc_sec_title">Cytokines determination</h3>
<p id="Par42">Cytokine production was measured from serum collected after primary and booster immunizations. Compared to blank or control groups, the use of naked pVAX1-TgIMC1 plasmid or its nanoparticle-encapsulated forms effectively stimulated the production of cytokines IFN-γ (Fig. <a href="#Fig6" class="usa-link">6</a>A), IL-4 (Fig. <a href="#Fig6" class="usa-link">6</a>B), IL-10 (Fig. <a href="#Fig6" class="usa-link">6</a>C), and IL-17 (Fig. <a href="#Fig6" class="usa-link">6</a>D). As shown in Fig. <a href="#Fig6" class="usa-link">6</a>A and B, and <a href="#Fig6" class="usa-link">6</a>E, mice immunized with pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS nanospheres exhibited significantly increased secretion of IFN-γ, IL-4, and IL-17 compared to the control group (<em>p</em> &lt; 0.001).</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374472_12917_2025_4961_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522c/12374472/71c91536bf80/12917_2025_4961_Fig6_HTML.jpg" loading="lazy" id="d33e940" height="508" width="669" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Cytokine secretion levels for IFN-γ (<strong>A</strong>), IL-4 (<strong>B</strong>), IL-10 (<strong>C</strong>), IL-17 (<strong>D</strong>), IL-6 (<strong>E</strong>), and TGF-β (<strong>F</strong>) were measured in serum collected at weeks 0, 2, and 4 using ELISA kits. Each serum sample was tested once. Statistical significance was evaluated using one-way ANOVA, followed by Dunnett’s test and Bonferroni correction. Pairwise comparisons of pVAX1-TgIMC1, pVAX1-TgIMC1/PLGA, and pVAX1-TgIMC1/CS groups were conducted. Results are expressed as mean ± SD (<em>n</em> = 5). Significant differences compared to blank or control groups are indicated as *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001</p></figcaption></figure><p id="Par43">The results demonstrated that the level of IL-10 in the pVAX1-TgIMC1/CS group was significantly higher than in the pVAX1-TgIMC1/PLGA group (<em>p</em> &lt; 0.001, Fig. <a href="#Fig6" class="usa-link">6</a>D). In contrast, IL-6 levels were significantly downregulated in both nanoparticle groups compared to the control, with the pVAX1-TgIMC1/PLGA group showing the most pronounced reduction (<em>p</em> &lt; 0.001, Fig. <a href="#Fig6" class="usa-link">6</a>C). No statistically significant differences in TGF-β levels were observed between the control and immunized groups (<em>p</em> &gt; 0.05, Fig. <a href="#Fig6" class="usa-link">6</a>F).</p></section><section id="Sec20"><h3 class="pmc_sec_title">Vaccine boosted spleen dendritic cell activity</h3>
<p id="Par45">CD83 and CD86 are key molecules for assessing the maturation and antigen-presenting functions of DCs, with their high expression often closely associated with more effective T-cell activation and enhanced immune responses. To evaluate the impact of nanoparticles on DC maturation, splenic cells were collected after both the primary and booster immunizations from immunized animals. DCs were isolated from the splenic cell suspension using density gradient centrifugation, followed by flow cytometry analysis of CD83 and CD86 expression. As shown in Figs. <a href="#Fig7" class="usa-link">7</a>A-C, both pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS nanospheres significantly increased the expression frequency of CD83 and CD86 following both primary and booster immunizations compared to the control group (<em>p</em> &lt; 0.01; Figs. <a href="#Fig7" class="usa-link">7</a>A, B). Furthermore, data analysis indicated that after the booster immunization, pVAX1-TgIMC1/PLGA nanoparticles were more effective in inducing CD83 and CD86 expression compared to the naked pVAX1-TgIMC1 plasmid. These findings demonstrate that both the pVAX1-TgIMC1 plasmid and its nanoparticle forms play important roles in inducing the expression of DC surface molecules, with effects varying by nanoparticle type and immunization frequency.</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374472_12917_2025_4961_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522c/12374472/9fd1bd8b3248/12917_2025_4961_Fig7_HTML.jpg" loading="lazy" id="d33e999" height="492" width="669" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Flow cytometry was used to analyze CD83<sup>+</sup> (<strong>A</strong>) and CD86<sup>+</sup> (<strong>B</strong>) molecules on DC surfaces in the spleens of immunized mice. Five mice per group were sacrificed, and their splenic cells were analyzed. <strong>C</strong> Shows the relative numbers of CD11c<sup>+</sup>CD83<sup>+</sup> and CD11c<sup>+</sup>CD86<sup>+</sup> cells. Results are presented as mean ± standard deviation (SD) (<em>n</em> = 5). Statistical significance was evaluated using one-way ANOVA, followed by Dunnett’s test. After Bonferroni correction, pairwise comparisons of rTgIMC1 protein, pVAX1-TgIMC1/PLGA, and pVAX1-TgIMC1/CS groups were performed using ANOVA. Significant differences compared to the control group are indicated as *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, and ***<em>p</em> &lt; 0.001</p></figcaption></figure><p id="Par47">Since MHC-I primarily presents endogenous antigens to CD8<sup>+</sup> T cells, thereby triggering cytotoxic immune responses, while MHC-II presents exogenous antigens to CD4<sup>+</sup> T cells, facilitating the regulation of both humoral and cellular immune responses. To explore their impact on these pathways, the effects of pVAX1-TgIMC1/CS and pVAX1-TgIMC1/PLGA nanoparticles on antigen presentation were investigated. Splenocytes were harvested and DCs were enriched by discontinuous density gradient centrifugation using OptiPrep (Sigma-Aldrich). Briefly, single-cell suspensions were layered over 14.5% OptiPrep solution and centrifuged at 600×g for 15 min at 4 °C. The low-density interface containing DCs was collected and washed twice with PBS. The expression of MHC-I and MHC-II on CD11c<sup>+</sup> DCs was then analyzed by flow cytometry. As shown in Figs. <a href="#Fig8" class="usa-link">8</a>A-C, booster immunization with the naked pVAX1-TgIMC1 plasmid and pVAX1-TgIMC1/CS nanoparticles induced significantly higher levels of MHC-I expression on DCs compared to the control group (<em>p</em> &lt; 0.01). Furthermore, both the pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS groups exhibited significantly enhanced expression levels of MHC-II molecules on DCs following both primary and booster immunizations compared to the control group (<em>p</em> &lt; 0.01). The results also demonstrated that the expression levels of MHC-II in the pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS groups were higher than those in the pVAX1-TgIMC1 group after both immunizations. These findings suggest that the rTgIMC1 protein and its nanoparticle formulations effectively activate the antigen-presenting function of dendritic cells.</p>
<figure class="fig xbox font-sm" id="Fig8"><h4 class="obj_head">Fig. 8.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374472_12917_2025_4961_Fig8_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522c/12374472/8391fb858e05/12917_2025_4961_Fig8_HTML.jpg" loading="lazy" id="d33e1058" height="520" width="669" alt="Fig. 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Flow cytometry was used to analyze MHC molecule expression on DCs. Five animals per group were sacrificed, and splenic cells were studied. Bar graphs display the ratios of MHC-I (<strong>A</strong>) and MHC-II molecules (<strong>B</strong>) on splenic DCs, while dot plots (<strong>C</strong>) show the percentages of CD11c<sup>+</sup> MHC-I<sup>+</sup> and CD11c<sup>+</sup> MHC-II<sup>+</sup> cells. Results are presented as mean ± SD (<em>n</em> = 5). Statistical significance was evaluated using one-way ANOVA, followed by Dunnett’s test. After Bonferroni correction, pairwise comparisons of pVAX1-TgIMC1, pVAX1-TgIMC1/PLGA, and pVAX1-TgIMC1/CS groups were conducted. Significant differences compared to the control group are indicated as *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, and ***<em>p</em> &lt; 0.001</p></figcaption></figure></section><section id="Sec21"><h3 class="pmc_sec_title">Vaccine enhances T cell growth</h3>
<p id="Par49">To determine whether nanoparticles enhance T lymphocyte responses, splenic cells were isolated three days after booster immunization, and their proliferation response to recombinant rTgIMC1 protein stimulation was measured. As shown in Fig. <a href="#Fig9" class="usa-link">9</a>, animals immunized with pVAX1-TgIMC1/CS and TgIMC1- PLGA nanoparticles exhibited significant proliferation compared to control groups. Compared to the naked pVAX1-TgIMC1 plasmid, pVAX1-TgIMC1/CS nanoparticles significantly promoted splenic lymphocyte proliferation (<em>p</em> &lt; 0.01), indicating that chitosan nanoparticles have an advantage in inducing T lymphocyte proliferation.</p>
<figure class="fig xbox font-sm" id="Fig9"><h4 class="obj_head">Fig. 9.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522c/12374472/16acd3b7a72f/12917_2025_4961_Fig9_HTML.jpg" loading="lazy" id="d33e1088" height="534" width="590" alt="Fig. 9"></p>
<div class="p text-right font-secondary"><a href="figure/Fig9/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Splenic cells from three mice per group were collected and divided into three portions. Splenic cells were stimulated with rTgIMC1 (10 µg/ml) for 72 h prior to proliferation assay. Each lymphocyte portion was tested once. Statistical significance was evaluated using one-way ANOVA, followed by Dunnett’s test. Results are presented as mean ± SD (<em>n</em> = 9). After Bonferroni correction, pairwise comparisons of pVAX1-TgIMC1, pVAX1-TgIMC1/PLGA, and pVAX1-TgIMC1/CS groups were conducted. Significant differences compared to the control group are indicated as **<em>p</em> &lt; 0.01 and ***<em>p</em> &lt; 0.001</p></figcaption></figure><p id="Par51">To assess the influence of PLGA and chitosan nanoparticles on T lymphocyte responses, CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocyte expression levels in splenic cells were analyzed using flow cytometry. As shown in Figs. <a href="#Fig10" class="usa-link">10</a>A, B, compared to the control group, both pVAX1-TgIMC1/CS and pVAX1-TgIMC1/PLGA nanoparticles significantly increased the levels of splenic CD4⁺ T and CD8⁺ T lymphocytes following the primary immunization (<em>p</em> &lt; 0.05, Figs. <a href="#Fig10" class="usa-link">10</a>A, B). The results further indicated that after both the primary and booster immunizations, the expression of CD4⁺ T cells in the pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS groups was significantly higher than that in the pVAX1-TgIMC1 group. Moreover, following the booster immunization, the expression of CD8⁺ T cells in the pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS groups was also significantly elevated compared to the pVAX1-TgIMC1 group (<em>p</em> &lt; 0.001).</p>
<figure class="fig xbox font-sm" id="Fig10"><h4 class="obj_head">Fig. 10.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374472_12917_2025_4961_Fig10_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522c/12374472/c8da2b70a528/12917_2025_4961_Fig10_HTML.jpg" loading="lazy" id="d33e1153" height="564" width="744" alt="Fig. 10"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig10/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>CD4<sup>+</sup> (<strong>A</strong>) and CD8<sup>+</sup> (<strong>B</strong>) T lymphocytes in the splenic cells of five mice per group were analyzed using flow cytometry. Dot plots (<strong>C</strong>) show the relative percentages of CD3e<sup>+</sup>CD4<sup>+</sup> and CD3e<sup>+</sup>CD8<sup>+</sup> cells. Results are expressed as mean ± SD (<em>n</em> = 5). Statistical significance was assessed using one-way ANOVA, followed by Dunnett’s test. After Bonferroni correction, pairwise comparisons of pVAX1-TgIMC1, pVAX1-TgIMC1/PLGA, and pVAX1-TgIMC1/CS groups were conducted. Significant differences compared to the control group are indicated as *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001</p></figcaption></figure></section><section id="Sec22"><h3 class="pmc_sec_title">Immunohistochemistry of spleen in immune mice and cardiac <em>Toxoplasma</em> load</h3>
<p id="Par53">Fourteen days after the booster immunization, mice were challenged with an intraperitoneal injection of 100 tachyzoites of the highly virulent <em>T. gondii</em> RH strain. Four days post-challenge, the mice were euthanized under the supervision of the Ethics Committee of Ningxia University, and spleen tissues were collected and processed into paraffin sections. As shown in Fig. <a href="#Fig11" class="usa-link">11</a>, mice immunized with rTgIMC1 protein, pVAX1-TgIMC1/PLGA, and pVAX1-TgIMC1/CS nanospheres exhibited reduced <em>T. gondii</em> infection in the spleen. These results suggest that nanosphere-based immunization provides protective immunity against toxoplasmosis in mice, effectively inhibiting the growth of <em>T. gondii</em> tachyzoites to a certain extent.</p>
<figure class="fig xbox font-sm" id="Fig11"><h4 class="obj_head">Fig. 11.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374472_12917_2025_4961_Fig11_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522c/12374472/ee5e070fe4c4/12917_2025_4961_Fig11_HTML.jpg" loading="lazy" id="d33e1193" height="165" width="669" alt="Fig. 11"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig11/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Four days post-challenge, three mice were euthanized for spleen collection (<em>n</em> = 3). Paraffin-embedded sections were incubated with rabbit anti-<em>T. gondii</em> primary antibody (1:500, Abcam, UK) followed by CY3-conjugated goat anti-rabbit IgG secondary antibody (1:1000, ABclonal, China). One representative section per spleen was analyzed, with random high-magnification fields selected for observation (scale bar = 100 μm). The specific antibody staining confirms successful <em>T. gondii</em> detection in infected tissues, with appropriate controls validating the signal specificity</p></figcaption></figure><p id="Par55">Fourteen days after booster immunization (day 29), the mice were challenged with 100 tachyzoites of the virulent <em>T. gondii</em> RH strain, and parasite burdens in the heart tissue were evaluated on day 6 post-infection using qPCR. As shown in Fig. <a href="#Fig12" class="usa-link">12</a>, parasite loads were significantly reduced in the pVAX1-TgIMC1, pVAX1-TgIMC1/PLGA, and pVAX1-TgIMC1/CS nanoparticle groups compared to the control group (<em>p</em> &lt; 0.001). Moreover, pVAX1-TgIMC1/CS nanoparticles showed stronger anti-toxoplasmosis effects than the naked pVAX1-TgIMC1 plasmid (<em>p</em> &lt; 0.001), with nearly a twofold reduction in parasite burden. These findings highlight the crucial role of nanomaterials in enhancing immune protection.</p>
<figure class="fig xbox font-sm" id="Fig12"><h4 class="obj_head">Fig. 12.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/522c/12374472/36827dbfd1d8/12917_2025_4961_Fig12_HTML.jpg" loading="lazy" id="d33e1233" height="503" width="590" alt="Fig. 12"></p>
<div class="p text-right font-secondary"><a href="figure/Fig12/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The parasite burden in heart tissue was measured as the copy number of a 529 bp <em>T. gondii</em> fragment using qPCR. Two weeks after booster immunization, animals were challenged with 100 tachyzoites, and the heart tissue was collected six days post-infection. Each sample was tested three times (<em>n</em> = 15). Statistical significance was analyzed using one-way ANOVA, followed by Dunnett’s test. Pairwise comparisons of pVAX1-TgIMC1, pVAX1-TgIMC1/PLGA, and pVAX1-TgIMC1/CS groups were conducted using independent t-tests. Values are presented as mean ± SD (<em>n</em> = 15). Significant differences compared to the control group are indicated (**<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001)</p></figcaption></figure></section></section><section id="Sec23"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par57">This study aimed to develop a novel DNA vaccine delivery system by encapsulating the pVAX1-TgIMC1 plasmid with nanomaterials, offering a new strategy for the prevention and control of <em>Toxoplasma gondii</em> infections. <em>T. gondii</em> is a globally distributed zoonotic protozoan pathogen capable of establishing chronic infections in various hosts, posing significant health and economic threats [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. Current efforts to prevent and control <em>T. gondii</em> infections face significant challenges in both clinical and agricultural contexts, and no commercially available vaccine provides comprehensive and long-lasting protection [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>–<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. DNA vaccines have garnered extensive attention over the past two decades due to their ability to express foreign antigens directly in host cells, eliciting specific humoral and cellular immune responses, thus offering a promising approach for the development of <em>T. gondii</em> vaccines [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>, <a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. However, the practical application of DNA vaccines remains hindered by limitations such as low delivery efficiency, susceptibility of plasmids to degradation, and suboptimal immunogenicity [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>–<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>].</p>
<p id="Par58">In recent years, nanomaterials have made remarkable progress in drug and vaccine delivery. These materials not only improve antigen stability and delivery efficiency but also allow for the modulation of immunological properties by controlling nanoparticle size, surface charge, and surface ligands [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Among these, poly (lactic-co-glycolic acid) (PLGA), a biodegradable polymer, has been widely utilized in drug and vaccine delivery due to its ability to protect DNA from enzymatic degradation and provide sustained antigen release [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>, <a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. However, the inherently negative surface charge of PLGA nanoparticles limits their mucosal adhesion and cellular uptake, posing challenges to antigen delivery efficiency and immune response activation [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>, <a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. In contrast, chitosan, a cationic polysaccharide, provides several advantages. It binds tightly to DNA, facilitates cellular uptake, and protects DNA from nuclease degradation. Moreover, its biocompatibility and low toxicity make it an ideal non-viral delivery vector capable of stimulating immune responses via innate immune pathways such as cGAS-STING [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>–<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>]. Additionally, chitosan exhibits antimicrobial properties, which may further enhance the protective efficacy of vaccines by inhibiting the growth of pathogenic microorganisms [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>].</p>
<p id="Par59">In this study, pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS nanoparticles were successfully constructed and systematically evaluated for their immunological properties and biosafety. Using optimized solvent evaporation and ionic gelation techniques, the resulting PLGA and chitosan nanoparticles exhibited regular spherical morphologies with particle sizes typically under 200 nm. This size range is conducive to uptake by antigen-presenting cells such as DCs and MACROPHAGES, enhancing antigen presentation and the induction of specific immune responses [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>, <a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. Previous studies have indicated that nanoparticles smaller than 200 nm are more effectively internalized by DCs, thereby enhancing immunogenicity [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]. Additionally, lyophilization effectively removed residual organic solvents, improved storage stability, and reduced potential toxicity associated with solvent residues [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. Experimental results demonstrated no significant toxicity in animal models immunized with the nanoparticles, as evidenced by unaltered serum biochemical parameters (e.g., BUN, Cr) and normal behavior compared to controls. These findings confirm the biosafety of the nanoparticle-based delivery strategy and are consistent with prior reports of the low toxicity and high biocompatibility of PLGA and chitosan nanoparticles.</p>
<p id="Par60">The immune protection against <em>T. gondii</em> involves both humoral and cellular immunity. Humoral immunity, mediated by B cells, protects hosts through the secretion of specific antibodies such as IgG, while cellular immunity relies on T cell responses and the secretion of cytokines such as IFN-γ, IL-4, and IL-17 to eliminate parasites or inhibit their proliferation [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>–<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>]. In this study, mice immunized with pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS nanoparticles exhibited significantly higher levels of IgG and its subclasses, IgG1 and IgG2a, compared to controls immunized with the rTgIMC1 protein alone. IgG1 is associated with Th2-type immune responses, while IgG2a is linked to Th1-type responses [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>]. The simultaneous increase in IgG1 and IgG2a levels indicates that these nanoparticles can activate both Th1- and Th2-associated immune pathways, resulting in a balanced mixed immune response. This result aligns with studies suggesting that nanoparticle-based vaccines can induce multifaceted immune responses [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>–<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>], highlighting the potential of nanomaterial-mediated DNA vaccine delivery to achieve comprehensive, balanced, and durable humoral immune protection. Enhanced humoral responses are crucial for neutralizing <em>T. gondii</em> invasion-related molecules, mitigating acute infections, and reducing cyst formation, thereby alleviating clinical symptoms and tissue damage [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>, <a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>].</p>
<p id="Par61">The immune responses elicited by <em>T. gondii</em> infection are regulated by a complex network of cytokines involving both innate and adaptive immunity. IFN-γ is recognized as a central cytokine in controlling <em>T. gondii</em> proliferation, as it activates MACROPHAGES and promotes lysosome-phagosome fusion to inhibit parasite replication [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>, <a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. In this study, IFN-γ levels were significantly elevated in mice immunized with nanoparticles, indicating a strong Th1-dominant cellular immune response. Concurrently, IL-4 levels were also upregulated. IL-4 plays a crucial role in maintaining immune homeostasis, assisting in Th2 response development, and interacting with IFN-γ to provide comprehensive host protection [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>, <a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>]. Notably, IL-10, an immunosuppressive cytokine that regulates excessive inflammation and prevents immunopathological damage, was upregulated in the nanovaccine groups, while TGF-β levels remained unchanged [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>]. This upregulation of IL-10 suggests that the immune system actively promotes immune tolerance while preventing excessive inflammatory activation, thereby minimizing tissue damage and optimizing the activation of B cells and T cells. Furthermore, IL-6, a pro-inflammatory cytokine linked to tissue damage during acute <em>T. gondii</em> infections, was elevated in the rTgIMC1 protein-only group but remained at baseline levels in the nanoparticle groups, indicating that the nanoparticles mitigated excessive inflammatory responses [<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>–<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>]. The significant elevation of IL-17 levels in nanoparticle-immunized mice suggests that these formulations effectively activated Th17-associated immune responses, which play a critical role in enhancing neutrophil recruitment and pathogen clearance during acute infection [<a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>, <a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>].</p>
<p id="Par62">The maturation and activation of DCs are essential for initiating and sustaining adaptive immune responses [<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>]. Enhanced expression of costimulatory molecules such as CD83 and CD86, as well as major histocompatibility complex molecules (MHC-I and MHC-II), promotes efficient antigen presentation and T cell activation [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>, <a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>]. In this study, all nanoparticle-immunized groups demonstrated significant increases in CD83 and CD86 expression, indicating effective promotion of DC maturation and activation. This enhancement may be attributed to the physicochemical properties of nanoparticles, such as size and surface charge, which facilitate DC uptake and antigen processing [<a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>]. Increased MHC-II expression further highlights the role of nanoparticles in activating CD4<sup>+</sup> T cell-mediated immune responses.</p>
<p id="Par63">While our nanoparticle vaccines achieved significant reduction in acute-phase parasite burden (Fig. <a href="#Fig11" class="usa-link">11</a>), the presence of residual Toxoplasma signals in vaccinated spleens reflects a well-characterized phenomenon in subunit vaccine development. Similar to other protein-based vaccines, our formulation demonstrates substantial but incomplete parasite clearance during early infection stages - an expected outcome given the biological complexity of establishing sterilizing immunity against intracellular pathogens. The necessary ethical protocol requiring euthanasia at onset of clinical symptoms (4 days post-challenge) prevented evaluation of later-stage immunity, though this early endpoint is standard for acute toxoplasmosis models to minimize animal suffering. Three complementary approaches could further elucidate this question: (1) utilizing engineered mouse models permitting extended observation, (2) establishing in vitro systems to track parasite survival in vaccinated host cells over time, and (3) implementing advanced imaging modalities to monitor infection progression non-invasively. Such studies would maintain ethical standards while revealing the vaccine’s full potential for sustained parasite control.</p>
<p id="Par64">The evaluation of immune protection efficacy is a critical aspect of vaccine development. In this study, challenge experiments using the highly virulent RH strain demonstrated significantly reduced <em>T. gondii</em> burdens in the hearts of mice immunized with pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS nanoparticles compared to controls. Histopathological analysis of spleen tissues further confirmed these results, revealing reduced parasite invasion and tissue damage in the nanoparticle groups.</p>
<p id="Par65">In conclusion, the pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS nanoparticles developed in this study demonstrated excellent structural and stability characteristics while exhibiting significant immunological advantages. These nanoparticle formulations effectively induced robust humoral and cellular immune responses, promoted DC maturation, and activated multiple T cell subsets, thereby significantly reducing acute-phase <em>T. gondii</em> burdens. Three key limitations should be noted: (1) The acute challenge model precluded assessment of chronic infection control; (2) Ethical endpoints at 4 days post-infection limited observation of memory immune clearance; (3) Residual parasite detection (Fig. <a href="#Fig11" class="usa-link">11</a>) suggests the need for adjuvant optimization. Nevertheless, our PLGA/CS system represents a major advancement as it is the first nanovaccine demonstrating against <em>T. gondii</em>, the nanoparticle delivery strategy established here provides a solid foundation for the future optimization and practical application of <em>T. gondii</em> DNA vaccines.</p></section><section id="Sec24"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par66">In summary, this study validated the potential application of PLGA and CS nanoparticles in the development of <em>Toxoplasma gondii</em> vaccines. The experimental results demonstrated that nanoparticle-based delivery systems exhibit excellent performance in improving vaccine stability, delivery efficiency, and immunogenicity. In vivo experiments revealed that the constructed pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS nanoparticles significantly enhanced the production of specific antibodies, induced a balanced Th1 and Th2 mixed immune response, and promoted dendritic cell (DC) maturation and antigen presentation. These findings highlight the promise of nanomaterial-based DNA vaccine strategies as an effective approach for controlling <em>T. gondii</em> infections. Additionally, the pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS nanoparticles, referred to as nanovaccines, were shown to significantly inhibit parasite invasion in the spleen and reduce parasite burdens in the host. These results suggest that pVAX1-TgIMC1/PLGA and pVAX1-TgIMC1/CS nanoparticles are promising candidates for preventing acute toxoplasmosis. However, given the complexity of chronic <em>T. gondii</em> infections and their long-term impact on host immunity, further optimization of vaccine formulations and validation in larger-scale animal models will be necessary to establish a stronger basis for clinical application.</p></section><section id="Sec25"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12374472/bin/12917_2025_4961_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (4.3MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12374472/bin/12917_2025_4961_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2</a><sup> (4.5MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM3"><div class="media p"><div class="caption">
<a href="/articles/instance/12374472/bin/12917_2025_4961_MOESM3_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 3</a><sup> (595.7KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM4"><div class="media p"><div class="caption">
<a href="/articles/instance/12374472/bin/12917_2025_4961_MOESM4_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 4</a><sup> (982KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM5"><div class="media p"><div class="caption">
<a href="/articles/instance/12374472/bin/12917_2025_4961_MOESM5_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 5</a><sup> (182.2KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We sincerely thank Professor Li Xiangrui from Nanjing Agricultural University, Nanjing, China, for providing the Toxoplasma gondii RH strain (Type I).</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>PLGA</dt>
<dd><p id="Par70">poly (lactic-co-glycolic acid)</p></dd>
<dt>BUN</dt>
<dd><p id="Par71">blood urea nitrogen</p></dd>
<dt>Cr</dt>
<dd><p id="Par72">creatinine</p></dd>
<dt>DCM</dt>
<dd><p id="Par73">dichloromethane</p></dd>
<dt>DCs</dt>
<dd><p id="Par74">dendritic cells</p></dd>
<dt>DMEM</dt>
<dd><p id="Par75">Dulbecco’s Modified Eagle’s Medium</p></dd>
<dt>EE</dt>
<dd><p id="Par76">encapsulation efficiency</p></dd>
<dt>ELISA</dt>
<dd><p id="Par77">enzyme linked immunosorbent</p></dd>
<dt>FBS</dt>
<dd><p id="Par78">fetal bovine serum</p></dd>
<dt>IFN</dt>
<dd><p id="Par79">interferon-gamma</p></dd>
<dt>IL</dt>
<dd><p id="Par80">interleukin</p></dd>
<dt>PVDF</dt>
<dd><p id="Par81">polyvinylidene fluoride</p></dd>
<dt>PYR</dt>
<dd><p id="Par82">pyrimethamine</p></dd>
<dt>qPCR</dt>
<dd><p id="Par83">quantitative real-time PCR</p></dd>
<dt>SEM</dt>
<dd><p id="Par84">scanning electron microscope</p></dd>
<dt>SPF</dt>
<dd><p id="Par85">specific pathogen free</p></dd>
<dt>STAg</dt>
<dd><p id="Par86">soluble tachyzoite antigens</p></dd>
<dt>TGF</dt>
<dd><p id="Par87">transforming growth factor</p></dd>
<dt>TgIMC1</dt>
<dd><p id="Par88"><em>T. gondii</em> Inner Membrane Complex Protein 1</p></dd>
<dt>TMB</dt>
<dd><p id="Par89">3,3’,5,5’-tetramethylbenzidine</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>ZY designed the research. YY provided financial support. PZ and YF conducted the research with assistance from YJ and TL. YL, WQ, and JW analyzed the data. YF wrote the manuscript. LZ and ZY participated in the revision of the manuscript. All authors contributed to data interpretation and approved the final version.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This research was funded by the High Level Scientific and Technological Talents Project of Lvliang City (2023RC-2-5), Scientific Research Start Funds for Advanced Talent in Ningxia Province (2024BEH04076), Ningxia Agricultural Science and Technology Independent Innovation Special Project – Scientific and Technological Innovation Guidance Project (NKYG-25-22), and National Natural Science Foundation of China (NSFC, 72203117).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The raw data supporting the conclusions of this article will be made available by the corresponding author, without undue reservation.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar4"><h3 class="pmc_sec_title">Ethics approval</h3>
<p id="Par67">The animal trials were approved by the Animal Ethics Committee, Ningxia University, Yinchuan, P.R. China. Approval number: NXU-2023-083 (for mouse trials), NXU-2023-086 (for rat trials). All the experimental design, animal management, injection, and operations were strictly followed the Ethics Procedures and Guidelines of the People’s Republic of China and were supervised by the Animal Ethics Committee, Ningxia University, Yinchuan, P.R. China.</p></section><section id="FPar1"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par68">Not applicable.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par69">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>ZhengQing Yu, Email: yuzhengqing@nxu.edu.cn.</p>
<p>TingLi Liu, Email: LTL1114@163.com.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Hill D, Dubey JP. <em>Toxoplasma gondii</em>: transmission, diagnosis and prevention. Clin Microbiol Infect. 2002;8(10):634–40.
</cite> [<a href="https://doi.org/10.1046/j.1469-0691.2002.00485.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12390281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hill%20D,%20Dubey%20JP.%20Toxoplasma%20gondii:%20transmission,%20diagnosis%20and%20prevention.%20Clin%20Microbiol%20Infect.%202002;8(10):634%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Montoya JG, Liesenfeld O, Toxoplasmosis. Lancet (London England). 2004;363(9425):1965–76.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(04)16412-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15194258/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Montoya%20JG,%20Liesenfeld%20O,%20Toxoplasmosis.%20Lancet%20(London%20England).%202004;363(9425):1965%E2%80%9376." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25(2):264–96.
</cite> [<a href="https://doi.org/10.1128/CMR.05013-11" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3346298/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22491772/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Robert-Gangneux%20F,%20Dard%C3%A9%20ML.%20Epidemiology%20of%20and%20diagnostic%20strategies%20for%20toxoplasmosis.%20Clin%20Microbiol%20Rev.%202012;25(2):264%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Tenter AM, Heckeroth AR, Weiss LM. <em>Toxoplasma gondii</em>: from animals to humans. Int J Parasitol. 2000;30(12–13):1217–58.
</cite> [<a href="https://doi.org/10.1016/s0020-7519(00)00124-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3109627/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11113252/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tenter%20AM,%20Heckeroth%20AR,%20Weiss%20LM.%20Toxoplasma%20gondii:%20from%20animals%20to%20humans.%20Int%20J%20Parasitol.%202000;30(12%E2%80%9313):1217%E2%80%9358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Kim K, Weiss LM. <em>Toxoplasma gondii</em>: the model apicomplexan. Int J Parasitol. 2004;34(3):423–32.
</cite> [<a href="https://doi.org/10.1016/j.ijpara.2003.12.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3086386/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15003501/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20K,%20Weiss%20LM.%20Toxoplasma%20gondii:%20the%20model%20apicomplexan.%20Int%20J%20Parasitol.%202004;34(3):423%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Elbez-Rubinstein A, Ajzenberg D, Dardé M-L, et al. Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J Infect Dis. 2009;199(2):280–5.
</cite> [<a href="https://doi.org/10.1086/595793" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19032062/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Elbez-Rubinstein%20A,%20Ajzenberg%20D,%20Dard%C3%A9%20M-L,%20et%20al.%20Congenital%20toxoplasmosis%20and%20reinfection%20during%20pregnancy:%20case%20report,%20strain%20characterization,%20experimental%20model%20of%20reinfection,%20and%20review.%20J%20Infect%20Dis.%202009;199(2):280%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Montoya JG, Remington JS. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis. 1996;23(2):277–82.
</cite> [<a href="https://doi.org/10.1093/clinids/23.2.277" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8842263/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Montoya%20JG,%20Remington%20JS.%20Toxoplasmic%20chorioretinitis%20in%20the%20setting%20of%20acute%20acquired%20toxoplasmosis.%20Clin%20Infect%20Dis.%201996;23(2):277%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Basit KA, Nasir S, Vohra E, et al. Toxoplasmosis in an immunocompetent patient. Pakistan J Med Sci. 2018;34(6):1579–81.</cite> [<a href="https://doi.org/10.12669/pjms.346.15016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6290221/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30559827/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Basit%20KA,%20Nasir%20S,%20Vohra%20E,%20et%20al.%20Toxoplasmosis%20in%20an%20immunocompetent%20patient.%20Pakistan%20J%20Med%20Sci.%202018;34(6):1579%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 1992;15(2):211–22.</cite> [<a href="https://doi.org/10.1093/clinids/15.2.211" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1520757/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Luft%20BJ,%20Remington%20JS.%20Toxoplasmic%20encephalitis%20in%20AIDS.%20Clin%20Infect%20Diseases:%20Official%20Publication%20Infect%20Dis%20Soc%20Am.%201992;15(2):211%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Layton J, Theiopoulou DC, Rutenberg D, et al. Clinical spectrum, radiological findings, and outcomes of severe toxoplasmosis in immunocompetent hosts: a systematic review. Pathogens (Basel Switzerland). 2023;12(4):543.
</cite> [<a href="https://doi.org/10.3390/pathogens12040543" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10145896/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37111429/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Layton%20J,%20Theiopoulou%20DC,%20Rutenberg%20D,%20et%20al.%20Clinical%20spectrum,%20radiological%20findings,%20and%20outcomes%20of%20severe%20toxoplasmosis%20in%20immunocompetent%20hosts:%20a%20systematic%20review.%20Pathogens%20(Basel%20Switzerland).%202023;12(4):543." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Guo M, Dubey JP, Hill D, et al. Prevalence and risk factors for <em>Toxoplasma gondii</em> infection in meat animals and meat products destined for human consumption. J Food Prot. 2015;78(2):457–76.
</cite> [<a href="https://doi.org/10.4315/0362-028X.JFP-14-328" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25710166/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20M,%20Dubey%20JP,%20Hill%20D,%20et%20al.%20Prevalence%20and%20risk%20factors%20for%20Toxoplasma%20gondii%20infection%20in%20meat%20animals%20and%20meat%20products%20destined%20for%20human%20consumption.%20J%20Food%20Prot.%202015;78(2):457%E2%80%9376." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Lyons RE, Mcleod R, Roberts CW. <em>Toxoplasma gondii</em> tachyzoite-bradyzoite interconversion. Trends Parasitol. 2002;18(5):198–201.
</cite> [<a href="https://doi.org/10.1016/s1471-4922(02)02248-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11983592/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lyons%20RE,%20Mcleod%20R,%20Roberts%20CW.%20Toxoplasma%20gondii%20tachyzoite-bradyzoite%20interconversion.%20Trends%20Parasitol.%202002;18(5):198%E2%80%93201." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Dittmar AJ, Drozda AA, Blader IJ. Drug repurposing screening identifies novel compounds that effectively inhibit. Toxoplasma Gondii Growth mSphere. 2016;1(2):e00042–15.
</cite> [<a href="https://doi.org/10.1128/mSphere.00042-15" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4894684/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27303726/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dittmar%20AJ,%20Drozda%20AA,%20Blader%20IJ.%20Drug%20repurposing%20screening%20identifies%20novel%20compounds%20that%20effectively%20inhibit.%20Toxoplasma%20Gondii%20Growth%20mSphere.%202016;1(2):e00042%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Buxton D, A Innes E. A commercial vaccine for ovine toxoplasmosis. Parasitology. 1995;110(Suppl):S11–6.
</cite> [<a href="https://doi.org/10.1017/s003118200000144x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7784124/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Buxton%20D,%20A%20Innes%20E.%20A%20commercial%20vaccine%20for%20ovine%20toxoplasmosis.%20Parasitology.%201995;110(Suppl):S11%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Hasan T, Nishikawa Y. Advances in vaccine development and the immune response against toxoplasmosis in sheep and goats. Front Veterinary Sci. 2022;9:951584.</cite> [<a href="https://doi.org/10.3389/fvets.2022.951584" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9453163/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36090161/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hasan%20T,%20Nishikawa%20Y.%20Advances%20in%20vaccine%20development%20and%20the%20immune%20response%20against%20toxoplasmosis%20in%20sheep%20and%20goats.%20Front%20Veterinary%20Sci.%202022;9:951584." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Mévélec MN, Lakhrif Z, Dimier-Poisson I. Key limitations and new insights into the <em>Toxoplasma gondii</em> parasite stage switching for future vaccine development in human, livestock, and cats. Front Cell Infect Microbiol. 2020;10:607198.
</cite> [<a href="https://doi.org/10.3389/fcimb.2020.607198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7724089/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33324583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?M%C3%A9v%C3%A9lec%20MN,%20Lakhrif%20Z,%20Dimier-Poisson%20I.%20Key%20limitations%20and%20new%20insights%20into%20the%20Toxoplasma%20gondii%20parasite%20stage%20switching%20for%20future%20vaccine%20development%20in%20human,%20livestock,%20and%20cats.%20Front%20Cell%20Infect%20Microbiol.%202020;10:607198." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Kur J, Holec-Gąsior L, Hiszczyńska-Sawicka E. Current status of toxoplasmosis vaccine development. Expert Rev Vaccines. 2009;8(6):791–808.
</cite> [<a href="https://doi.org/10.1586/erv.09.27" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19485758/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kur%20J,%20Holec-G%C4%85sior%20L,%20Hiszczy%C5%84ska-Sawicka%20E.%20Current%20status%20of%20toxoplasmosis%20vaccine%20development.%20Expert%20Rev%20Vaccines.%202009;8(6):791%E2%80%93808." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Chu KB, Quan FS. Advances in <em>Toxoplasma gondii</em> vaccines: current strategies and challenges for vaccine development. Vaccines. 2021;9(5):413.
</cite> [<a href="https://doi.org/10.3390/vaccines9050413" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8143161/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33919060/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chu%20KB,%20Quan%20FS.%20Advances%20in%20Toxoplasma%20gondii%20vaccines:%20current%20strategies%20and%20challenges%20for%20vaccine%20development.%20Vaccines.%202021;9(5):413." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Zheng B, Lou D, Ding J, et al. GRA24-based DNA vaccine prolongs survival in mice challenged with a virulent <em>Toxoplasma gondii</em> strain. Front Immunol. 2019;10:418.
</cite> [<a href="https://doi.org/10.3389/fimmu.2019.00418" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6414464/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30894865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20B,%20Lou%20D,%20Ding%20J,%20et%20al.%20GRA24-based%20DNA%20vaccine%20prolongs%20survival%20in%20mice%20challenged%20with%20a%20virulent%20Toxoplasma%20gondii%20strain.%20Front%20Immunol.%202019;10:418." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Zhang X, Yuan H, Mahmmod YS, et al. Insight into the current <em>Toxoplasma gondii</em> DNA vaccine: a review Article. Expert Rev Vaccines. 2023;22(1):66–89.
</cite> [<a href="https://doi.org/10.1080/14760584.2023.2157818" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36508550/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20X,%20Yuan%20H,%20Mahmmod%20YS,%20et%20al.%20Insight%20into%20the%20current%20Toxoplasma%20gondii%20DNA%20vaccine:%20a%20review%20Article.%20Expert%20Rev%20Vaccines.%202023;22(1):66%E2%80%9389." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Harding CR, Meissner M. The inner membrane complex through development of <em>Toxoplasma gondii</em> and plasmodium. Cell Microbiol. 2014;16(5):632–41.
</cite> [<a href="https://doi.org/10.1111/cmi.12285" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4286798/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24612102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Harding%20CR,%20Meissner%20M.%20The%20inner%20membrane%20complex%20through%20development%20of%20Toxoplasma%20gondii%20and%20plasmodium.%20Cell%20Microbiol.%202014;16(5):632%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Chen AL, Kim EW, Toh JY et al. Novel components of the Toxoplasma inner membrane complex revealed by bioID. mBio. 2015, 6:e02357–14.</cite> [<a href="https://doi.org/10.1128/mBio.02357-14" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4337574/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25691595/" class="usa-link">PubMed</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Mann T, Gaskins E, Beckers C. Proteolytic processing of TgIMC1 during maturation of the membrane skeleton of <em>Toxoplasma gondii</em>. J Biol Chem. 2002;277(43):41240–6.
</cite> [<a href="https://doi.org/10.1074/jbc.M205056200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12177058/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mann%20T,%20Gaskins%20E,%20Beckers%20C.%20Proteolytic%20processing%20of%20TgIMC1%20during%20maturation%20of%20the%20membrane%20skeleton%20of%20Toxoplasma%20gondii.%20J%20Biol%20Chem.%202002;277(43):41240%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Gubbels MJ, Wieffer M, Striepen B. Fluorescent protein tagging in <em>Toxoplasma gondii</em>: identification of a novel inner membrane complex component conserved among apicomplexa. Mol Biochem Parasitol. 2004;137(1):99–110.
</cite> [<a href="https://doi.org/10.1016/j.molbiopara.2004.05.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15279956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gubbels%20MJ,%20Wieffer%20M,%20Striepen%20B.%20Fluorescent%20protein%20tagging%20in%20Toxoplasma%20gondii:%20identification%20of%20a%20novel%20inner%20membrane%20complex%20component%20conserved%20among%20apicomplexa.%20Mol%20Biochem%20Parasitol.%202004;137(1):99%E2%80%93110." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Pati R, Shevtsov M, Sonawane A. Nanoparticle vaccines against infectious diseases. Front Immunol. 2018;9:2224.
</cite> [<a href="https://doi.org/10.3389/fimmu.2018.02224" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6180194/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30337923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pati%20R,%20Shevtsov%20M,%20Sonawane%20A.%20Nanoparticle%20vaccines%20against%20infectious%20diseases.%20Front%20Immunol.%202018;9:2224." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Rocha CV, Gonçalves V, Da Silva MC, et al. PLGA-based composites for various biomedical applications. Int J Mol Sci. 2022;23(4):2034.
</cite> [<a href="https://doi.org/10.3390/ijms23042034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8876940/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35216149/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rocha%20CV,%20Gon%C3%A7alves%20V,%20Da%20Silva%20MC,%20et%20al.%20PLGA-based%20composites%20for%20various%20biomedical%20applications.%20Int%20J%20Mol%20Sci.%202022;23(4):2034." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Danhier F, Ansorena E, Silva JM, et al. PLGA-based nanoparticles: an overview of biomedical applications. J Controlled Release. 2012;161(2):505–22.</cite> [<a href="https://doi.org/10.1016/j.jconrel.2012.01.043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22353619/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Danhier%20F,%20Ansorena%20E,%20Silva%20JM,%20et%20al.%20PLGA-based%20nanoparticles:%20an%20overview%20of%20biomedical%20applications.%20J%20Controlled%20Release.%202012;161(2):505%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Zhao D, Yu S, Sun B, et al. Biomedical applications of Chitosan and its derivative nanoparticles. Polymers. 2018;10(4):462.
</cite> [<a href="https://doi.org/10.3390/polym10040462" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6415442/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30966497/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20D,%20Yu%20S,%20Sun%20B,%20et%20al.%20Biomedical%20applications%20of%20Chitosan%20and%20its%20derivative%20nanoparticles.%20Polymers.%202018;10(4):462." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Wang S, Zhao G, Wang W, et al. Pathogenicity of two <em>Toxoplasma gondii</em> strains in chickens of different ages infected via intraperitoneal injection. Avian Pathol. 2014;43(1):91–5.
</cite> [<a href="https://doi.org/10.1080/03079457.2013.874007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24325275/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20S,%20Zhao%20G,%20Wang%20W,%20et%20al.%20Pathogenicity%20of%20two%20Toxoplasma%20gondii%20strains%20in%20chickens%20of%20different%20ages%20infected%20via%20intraperitoneal%20injection.%20Avian%20Pathol.%202014;43(1):91%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Wang S, Fang Z, Huang X et al. The soluble tachyzoite antigen of <em>Toxoplasma gondii</em> has a protective effect on mouse allografts. Transpl. proc. 2013, 45(2):677–83.</cite> [<a href="https://doi.org/10.1016/j.transproceed.2012.02.036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23267786/" class="usa-link">PubMed</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Liu Q, Singla LD, Zhou H. Vaccines against <em>Toxoplasma gondii</em>: status, challenges and future directions. Hum Vaccines Immunotherapeutics. 2012;8(9):1305–8.</cite> [<a href="https://doi.org/10.4161/hv.21006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3579912/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22906945/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Q,%20Singla%20LD,%20Zhou%20H.%20Vaccines%20against%20Toxoplasma%20gondii:%20status,%20challenges%20and%20future%20directions.%20Hum%20Vaccines%20Immunotherapeutics.%202012;8(9):1305%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Kochanowsky JA, Koshy AA. Toxoplasma gondii. Curr Biol. 2018;28(14):R770–1.
</cite> [<a href="https://doi.org/10.1016/j.cub.2018.05.035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30040931/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kochanowsky%20JA,%20Koshy%20AA.%20Toxoplasma%20gondii.%20Curr%20Biol.%202018;28(14):R770%E2%80%931." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Rashidi S, Sánchez-Montejo J, Mansouri R, et al. Mining the proteome of <em>Toxoplasma</em> parasites seeking vaccine and diagnostic candidates. Animals. 2022;12(9):1098.
</cite> [<a href="https://doi.org/10.3390/ani12091098" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9099775/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35565525/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rashidi%20S,%20S%C3%A1nchez-Montejo%20J,%20Mansouri%20R,%20et%20al.%20Mining%20the%20proteome%20of%20Toxoplasma%20parasites%20seeking%20vaccine%20and%20diagnostic%20candidates.%20Animals.%202022;12(9):1098." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Daher D, Shaghlil A, Sobh E, et al. Comprehensive overview of <em>Toxoplasma gondii</em>-induced and associated diseases. Pathogens (Basel Switzerland). 2021;10(11):1351.
</cite> [<a href="https://doi.org/10.3390/pathogens10111351" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8625914/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34832507/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Daher%20D,%20Shaghlil%20A,%20Sobh%20E,%20et%20al.%20Comprehensive%20overview%20of%20Toxoplasma%20gondii-induced%20and%20associated%20diseases.%20Pathogens%20(Basel%20Switzerland).%202021;10(11):1351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Elsheikha HM, Marra CM, Zhu XQ. Epidemiology, pathophysiology, diagnosis, and management of cerebral toxoplasmosis. Clin Microbiol Rev. 2021;34(1):e00115–19.
</cite> [<a href="https://doi.org/10.1128/CMR.00115-19" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7690944/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33239310/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Elsheikha%20HM,%20Marra%20CM,%20Zhu%20XQ.%20Epidemiology,%20pathophysiology,%20diagnosis,%20and%20management%20of%20cerebral%20toxoplasmosis.%20Clin%20Microbiol%20Rev.%202021;34(1):e00115%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Warner RC, Chapman RC, Davis BN, et al. Review of DNA vaccine approaches against the parasite <em>Toxoplasma gondii</em>. J Parasitol. 2021;107(6):882–903.
</cite> [<a href="https://doi.org/10.1645/20-157" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8638329/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34852176/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Warner%20RC,%20Chapman%20RC,%20Davis%20BN,%20et%20al.%20Review%20of%20DNA%20vaccine%20approaches%20against%20the%20parasite%20Toxoplasma%20gondii.%20J%20Parasitol.%202021;107(6):882%E2%80%93903." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Mamaghani AJ, Fathollahi A, Arab-Mazar Z, et al. <em>Toxoplasma gondii</em> vaccine candidates: a concise review. Ir J Med Sci. 2023;192(1):231–61.
</cite> [<a href="https://doi.org/10.1007/s11845-022-02998-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8992420/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35394635/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mamaghani%20AJ,%20Fathollahi%20A,%20Arab-Mazar%20Z,%20et%20al.%20Toxoplasma%20gondii%20vaccine%20candidates:%20a%20concise%20review.%20Ir%20J%20Med%20Sci.%202023;192(1):231%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Li L, Petrovsky N. Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Rev Vaccines. 2016;15(3):313–29.
</cite> [<a href="https://doi.org/10.1586/14760584.2016.1124762" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4955855/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26707950/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20L,%20Petrovsky%20N.%20Molecular%20mechanisms%20for%20enhanced%20DNA%20vaccine%20immunogenicity.%20Expert%20Rev%20Vaccines.%202016;15(3):313%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Verma R, Khanna P. Development of <em>Toxoplasma gondii</em> vaccine: a global challenge. Hum Vaccines Immunotherapeutics. 2013;9(2):291–3.</cite> [<a href="https://doi.org/10.4161/hv.22474" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3859749/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23111123/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Verma%20R,%20Khanna%20P.%20Development%20of%20Toxoplasma%20gondii%20vaccine:%20a%20global%20challenge.%20Hum%20Vaccines%20Immunotherapeutics.%202013;9(2):291%E2%80%933." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Zhang NZ, Chen J, Wang M, et al. Vaccines against <em>Toxoplasma gondii</em>: new developments and perspectives. Expert Rev Vaccines. 2013;12(11):1287–99.
</cite> [<a href="https://doi.org/10.1586/14760584.2013.844652" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24093877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20NZ,%20Chen%20J,%20Wang%20M,%20et%20al.%20Vaccines%20against%20Toxoplasma%20gondii:%20new%20developments%20and%20perspectives.%20Expert%20Rev%20Vaccines.%202013;12(11):1287%E2%80%9399." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55(3):329–47.
</cite> [<a href="https://doi.org/10.1016/s0169-409x(02)00228-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12628320/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Panyam%20J,%20Labhasetwar%20V.%20Biodegradable%20nanoparticles%20for%20drug%20and%20gene%20delivery%20to%20cells%20and%20tissue.%20Adv%20Drug%20Deliv%20Rev.%202003;55(3):329%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Das A, Ali N. Nanovaccine: an emerging strategy. Expert Rev Vaccines. 2021;20(10):1273–90.
</cite> [<a href="https://doi.org/10.1080/14760584.2021.1984890" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34550859/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Das%20A,%20Ali%20N.%20Nanovaccine:%20an%20emerging%20strategy.%20Expert%20Rev%20Vaccines.%202021;20(10):1273%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Wang B, Dong Y, Cen Y, et al. PEI-PLGA nanoparticles significantly enhanced the immunogenicity of IsdB(137–361) proteins from Staphylococcus aureus. Immun Inflamm Dis. 2023;11(7):e928.
</cite> [<a href="https://doi.org/10.1002/iid3.928" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10336661/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37506158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20B,%20Dong%20Y,%20Cen%20Y,%20et%20al.%20PEI-PLGA%20nanoparticles%20significantly%20enhanced%20the%20immunogenicity%20of%20IsdB(137%E2%80%93361)%20proteins%20from%20Staphylococcus%20aureus.%20Immun%20Inflamm%20Dis.%202023;11(7):e928." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Keijzer C, Slütter B, Van Der Zee R, et al. PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity. PLoS ONE. 2011;6(11):e26684.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0026684" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3206834/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22073184/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Keijzer%20C,%20Sl%C3%BCtter%20B,%20Van%20Der%20Zee%20R,%20et%20al.%20PLGA,%20PLGA-TMC%20and%20TMC-TPP%20nanoparticles%20differentially%20modulate%20the%20outcome%20of%20nasal%20vaccination%20by%20inducing%20tolerance%20or%20enhancing%20humoral%20immunity.%20PLoS%20ONE.%202011;6(11):e26684." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Abd El Hady WE, Mohamed EA, Soliman OE, et al. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin. Int J Nanomed. 2019;14:7191–213.</cite> [<a href="https://doi.org/10.2147/IJN.S213836" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6732519/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31564873/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Abd%20El%20Hady%20WE,%20Mohamed%20EA,%20Soliman%20OE,%20et%20al.%20In%20vitro-in%20vivo%20evaluation%20of%20chitosan-PLGA%20nanoparticles%20for%20potentiated%20gastric%20retention%20and%20anti-ulcer%20activity%20of%20diosmin.%20Int%20J%20Nanomed.%202019;14:7191%E2%80%93213." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Silva AL, Soema PC, Slütter B, et al. PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity. Hum Vaccines Immunotherapeutics. 2016;12(4):1056–69.</cite> [<a href="https://doi.org/10.1080/21645515.2015.1117714" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4962933/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26752261/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Silva%20AL,%20Soema%20PC,%20Sl%C3%BCtter%20B,%20et%20al.%20PLGA%20particulate%20delivery%20systems%20for%20subunit%20vaccines:%20linking%20particle%20properties%20to%20immunogenicity.%20Hum%20Vaccines%20Immunotherapeutics.%202016;12(4):1056%E2%80%9369." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Roozbehani M, Falak R, Mohammadi M, et al. Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against <em>Toxoplasma gondii</em> infection. Vaccine. 2018;36(41):6124–32.
</cite> [<a href="https://doi.org/10.1016/j.vaccine.2018.08.068" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30181047/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Roozbehani%20M,%20Falak%20R,%20Mohammadi%20M,%20et%20al.%20Characterization%20of%20a%20multi-epitope%20peptide%20with%20selective%20MHC-binding%20capabilities%20encapsulated%20in%20PLGA%20nanoparticles%20as%20a%20novel%20vaccine%20candidate%20against%20Toxoplasma%20gondii%20infection.%20Vaccine.%202018;36(41):6124%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Layek B, Das S. Chapter 8 - Chitosan-based nanomaterials in drug delivery applications. In: Bera H, Hossain C, Saha M S, editors. Biopolymer-Based nanomaterials in drug delivery and biomedical applications. Cambridge: Academic; 2021. pp. 185–219.</cite> [<a href="https://scholar.google.com/scholar_lookup?Layek%20B,%20Das%20S.%20Chapter%208%20-%20Chitosan-based%20nanomaterials%20in%20drug%20delivery%20applications.%20In:%20Bera%20H,%20Hossain%20C,%20Saha%20M%20S,%20editors.%20Biopolymer-Based%20nanomaterials%20in%20drug%20delivery%20and%20biomedical%20applications.%20Cambridge:%20Academic;%202021.%20pp.%20185%E2%80%93219." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Jafernik K, Ładniak A, Blicharska E, et al. Chitosan-based nanoparticles as effective drug delivery systems-a review. Molecules. 2023;28(4):1963.
</cite> [<a href="https://doi.org/10.3390/molecules28041963" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9959713/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36838951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jafernik%20K,%20%C5%81adniak%20A,%20Blicharska%20E,%20et%20al.%20Chitosan-based%20nanoparticles%20as%20effective%20drug%20delivery%20systems-a%20review.%20Molecules.%202023;28(4):1963." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Li J, Cai C, Li J, et al. Chitosan-based nanomaterials for drug delivery. Molecules. 2018;23(10):2661.
</cite> [<a href="https://doi.org/10.3390/molecules23102661" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6222903/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30332830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20J,%20Cai%20C,%20Li%20J,%20et%20al.%20Chitosan-based%20nanomaterials%20for%20drug%20delivery.%20Molecules.%202018;23(10):2661." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Xiang SD, Wilson K, Day S, et al. Methods of effective conjugation of antigens to nanoparticles as non-inflammatory vaccine carriers. Methods (San Diego Calif). 2013;60(3):232–41.
</cite> [<a href="https://doi.org/10.1016/j.ymeth.2013.03.036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23643867/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xiang%20SD,%20Wilson%20K,%20Day%20S,%20et%20al.%20Methods%20of%20effective%20conjugation%20of%20antigens%20to%20nanoparticles%20as%20non-inflammatory%20vaccine%20carriers.%20Methods%20(San%20Diego%20Calif).%202013;60(3):232%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Allahyari M, Mohit E. Peptide/protein vaccine delivery system based on PLGA particles. Hum Vaccines Immunotherapeutics. 2016;12(3):806–28.</cite> [<a href="https://doi.org/10.1080/21645515.2015.1102804" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4964737/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26513024/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Allahyari%20M,%20Mohit%20E.%20Peptide/protein%20vaccine%20delivery%20system%20based%20on%20PLGA%20particles.%20Hum%20Vaccines%20Immunotherapeutics.%202016;12(3):806%E2%80%9328." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol. 2010;10(11):787–96.
</cite> [<a href="https://doi.org/10.1038/nri2868" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20948547/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bachmann%20MF,%20Jennings%20GT.%20Vaccine%20delivery:%20a%20matter%20of%20size,%20geometry,%20kinetics%20and%20molecular%20patterns.%20Nat%20Rev%20Immunol.%202010;10(11):787%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Schaffazick SR, Pohlmann AR, Dalla-Costa T, et al. Freeze-drying polymeric colloidal suspensions: nanocapsules, nanospheres and nanodispersion: A comparative study. Eur J Pharm Biopharm. 2003;56(3):501–5.
</cite> [<a href="https://doi.org/10.1016/s0939-6411(03)00139-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14602195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schaffazick%20SR,%20Pohlmann%20AR,%20Dalla-Costa%20T,%20et%20al.%20Freeze-drying%20polymeric%20colloidal%20suspensions:%20nanocapsules,%20nanospheres%20and%20nanodispersion:%20A%20comparative%20study.%20Eur%20J%20Pharm%20Biopharm.%202003;56(3):501%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Zorgi NE, Costa A, Galisteo AJ Jr., et al. Humoral responses and immune protection in mice immunized with irradiated <em>T. gondii</em> tachyzoites and challenged with three genetically distinct strains of <em>T. gondii</em>. Immunol Lett. 2011;138(2):187–96.
</cite> [<a href="https://doi.org/10.1016/j.imlet.2011.04.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21545808/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zorgi%20NE,%20Costa%20A,%20Galisteo%20AJ%20Jr.,%20et%20al.%20Humoral%20responses%20and%20immune%20protection%20in%20mice%20immunized%20with%20irradiated%20T.%20gondii%20tachyzoites%20and%20challenged%20with%20three%20genetically%20distinct%20strains%20of%20T.%20gondii.%20Immunol%20Lett.%202011;138(2):187%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Zhang Z, Li Y, Wang M, et al. Immune protection of Rhoptry protein 21 (ROP21) of <em>Toxoplasma gondii</em> as a DNA vaccine against toxoplasmosis. Front Microbiol. 2018;9:909.
</cite> [<a href="https://doi.org/10.3389/fmicb.2018.00909" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5951983/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29867820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20Z,%20Li%20Y,%20Wang%20M,%20et%20al.%20Immune%20protection%20of%20Rhoptry%20protein%2021%20(ROP21)%20of%20Toxoplasma%20gondii%20as%20a%20DNA%20vaccine%20against%20toxoplasmosis.%20Front%20Microbiol.%202018;9:909." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Pagheh AS, Sarvi S, Gholami S, et al. Protective efficacy induced by DNA prime and Recombinant protein boost vaccination with <em>Toxoplasma gondii</em> GRA14 in mice. Microb Pathog. 2019;134:103601.
</cite> [<a href="https://doi.org/10.1016/j.micpath.2019.103601" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31212035/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pagheh%20AS,%20Sarvi%20S,%20Gholami%20S,%20et%20al.%20Protective%20efficacy%20induced%20by%20DNA%20prime%20and%20Recombinant%20protein%20boost%20vaccination%20with%20Toxoplasma%20gondii%20GRA14%20in%20mice.%20Microb%20Pathog.%202019;134:103601." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Germann T, Bongartz M, Dlugonska H, et al. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur J Immunol. 1995;25(3):823–9.
</cite> [<a href="https://doi.org/10.1002/eji.1830250329" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7705414/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Germann%20T,%20Bongartz%20M,%20Dlugonska%20H,%20et%20al.%20Interleukin-12%20profoundly%20up-regulates%20the%20synthesis%20of%20antigen-specific%20complement-fixing%20IgG2a,%20IgG2b%20and%20IgG3%20antibody%20subclasses%20in%20vivo.%20Eur%20J%20Immunol.%201995;25(3):823%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Nabi H, Rashid I, Ahmad N, et al. Induction of specific humoral immune response in mice immunized with ROP18 nanospheres from <em>Toxoplasma gondii</em>. Parasitol Res. 2017;116(1):359–70.
</cite> [<a href="https://doi.org/10.1007/s00436-016-5298-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27785602/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nabi%20H,%20Rashid%20I,%20Ahmad%20N,%20et%20al.%20Induction%20of%20specific%20humoral%20immune%20response%20in%20mice%20immunized%20with%20ROP18%20nanospheres%20from%20Toxoplasma%20gondii.%20Parasitol%20Res.%202017;116(1):359%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Suzuki Y, Sa Q, Gehman M, et al. Interferon-gamma- and perforin-mediated immune responses for resistance against <em>Toxoplasma gondii</em> in the brain. Expert Rev Mol Med. 2011;13:e31.
</cite> [<a href="https://doi.org/10.1017/S1462399411002018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3372998/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22005272/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Suzuki%20Y,%20Sa%20Q,%20Gehman%20M,%20et%20al.%20Interferon-gamma-%20and%20perforin-mediated%20immune%20responses%20for%20resistance%20against%20Toxoplasma%20gondii%20in%20the%20brain.%20Expert%20Rev%20Mol%20Med.%202011;13:e31." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Ahmed N, French T, Rausch S, et al. <em>Toxoplasma</em> Co-infection prevents Th2 differentiation and leads to a helminth-specific Th1 response. Front Cell Infect Microbiol. 2017;7:341.
</cite> [<a href="https://doi.org/10.3389/fcimb.2017.00341" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5524676/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28791259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ahmed%20N,%20French%20T,%20Rausch%20S,%20et%20al.%20Toxoplasma%20Co-infection%20prevents%20Th2%20differentiation%20and%20leads%20to%20a%20helminth-specific%20Th1%20response.%20Front%20Cell%20Infect%20Microbiol.%202017;7:341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Zheng B, Ding J, Lou D, et al. The virulence-related MYR1 protein of <em>Toxoplasma gondii</em> as a novel DNA vaccine against toxoplasmosis in mice. Front Microbiol. 2019;10:734.
</cite> [<a href="https://doi.org/10.3389/fmicb.2019.00734" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6465564/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31024505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20B,%20Ding%20J,%20Lou%20D,%20et%20al.%20The%20virulence-related%20MYR1%20protein%20of%20Toxoplasma%20gondii%20as%20a%20novel%20DNA%20vaccine%20against%20toxoplasmosis%20in%20mice.%20Front%20Microbiol.%202019;10:734." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Murillo-Léon M, Bastidas-Quintero AM, Steinfeldt T. Decoding <em>Toxoplasma gondii</em> virulence: the mechanisms of IRG protein inactivation. Trends Parasitol. 2024;40(9):805–19.
</cite> [<a href="https://doi.org/10.1016/j.pt.2024.07.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39168720/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Murillo-L%C3%A9on%20M,%20Bastidas-Quintero%20AM,%20Steinfeldt%20T.%20Decoding%20Toxoplasma%20gondii%20virulence:%20the%20mechanisms%20of%20IRG%20protein%20inactivation.%20Trends%20Parasitol.%202024;40(9):805%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Ihara F, Yamamoto M. The role of IFN-γ-mediated host immune responses in monitoring and the elimination of <em>Toxoplasma gondii</em> infection. Int Immunol. 2024;36(5):199–210.
</cite> [<a href="https://doi.org/10.1093/intimm/dxae001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10989675/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38175650/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ihara%20F,%20Yamamoto%20M.%20The%20role%20of%20IFN-%CE%B3-mediated%20host%20immune%20responses%20in%20monitoring%20and%20the%20elimination%20of%20Toxoplasma%20gondii%20infection.%20Int%20Immunol.%202024;36(5):199%E2%80%93210." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Dupont CD, Christian DA, Hunter CA. Immune response and immunopathology during toxoplasmosis. Semin Immunopathol. 2012;34(6):793–813.
</cite> [<a href="https://doi.org/10.1007/s00281-012-0339-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3498595/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22955326/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dupont%20CD,%20Christian%20DA,%20Hunter%20CA.%20Immune%20response%20and%20immunopathology%20during%20toxoplasmosis.%20Semin%20Immunopathol.%202012;34(6):793%E2%80%93813." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Tawfeek GM, Abou-El-Naga IF, Hassan EME, et al. Protective efficacy of <em>Toxoplasma gondii</em> infected cells-derived exosomes against chronic murine toxoplasmosis. Acta Trop. 2023;248:107041.
</cite> [<a href="https://doi.org/10.1016/j.actatropica.2023.107041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37858877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tawfeek%20GM,%20Abou-El-Naga%20IF,%20Hassan%20EME,%20et%20al.%20Protective%20efficacy%20of%20Toxoplasma%20gondii%20infected%20cells-derived%20exosomes%20against%20chronic%20murine%20toxoplasmosis.%20Acta%20Trop.%202023;248:107041." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Zhao M, Zhang R, Xu X, et al. IL-10 reduces levels of apoptosis in <em>Toxoplasma gondii</em>-infected trophoblasts. PLoS ONE. 2013;8(2):e56455.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0056455" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3572055/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23418570/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20M,%20Zhang%20R,%20Xu%20X,%20et%20al.%20IL-10%20reduces%20levels%20of%20apoptosis%20in%20Toxoplasma%20gondii-infected%20trophoblasts.%20PLoS%20ONE.%202013;8(2):e56455." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Doherty CM, Patterson PR, Emeanuwa JA et al. T lymphocyte-dependent IL-10 down-regulates a cytokine storm driven by <em>Toxoplasma gondii</em> GRA24. mBio. 2024;15(11):e0145524.</cite> [<a href="https://doi.org/10.1128/mbio.01455-24" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11559025/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39440975/" class="usa-link">PubMed</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Silver JS, Stumhofer JS, Passos S, et al. IL-6 mediates the susceptibility of glycoprotein 130 hypermorphs to <em>Toxoplasma gondii</em>. J Immunol. 2011;187(1):350–60.
</cite> [<a href="https://doi.org/10.4049/jimmunol.1004144" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3119722/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21606248/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Silver%20JS,%20Stumhofer%20JS,%20Passos%20S,%20et%20al.%20IL-6%20mediates%20the%20susceptibility%20of%20glycoprotein%20130%20hypermorphs%20to%20Toxoplasma%20gondii.%20J%20Immunol.%202011;187(1):350%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Yan J, Wu B, Huang B, et al. Dectin-1-CD37 association regulates IL-6 expression during <em>Toxoplasma gondii</em> infection. Parasitol Res. 2014;113(8):2851–60.
</cite> [<a href="https://doi.org/10.1007/s00436-014-3946-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24870248/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yan%20J,%20Wu%20B,%20Huang%20B,%20et%20al.%20Dectin-1-CD37%20association%20regulates%20IL-6%20expression%20during%20Toxoplasma%20gondii%20infection.%20Parasitol%20Res.%202014;113(8):2851%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Muñoz M, Heimesaat MM, Danker K, et al. Interleukin (IL)-23 mediates <em>Toxoplasma gondii</em>-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J Exp Med. 2009;206(13):3047–59.
</cite> [<a href="https://doi.org/10.1084/jem.20090900" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2806449/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19995958/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mu%C3%B1oz%20M,%20Heimesaat%20MM,%20Danker%20K,%20et%20al.%20Interleukin%20(IL)-23%20mediates%20Toxoplasma%20gondii-induced%20immunopathology%20in%20the%20gut%20via%20matrixmetalloproteinase-2%20and%20IL-22%20but%20independent%20of%20IL-17.%20J%20Exp%20Med.%202009;206(13):3047%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Silva JL, Rezende-Oliveira K, Da Silva MV et al. IL-17-expressing CD4⁺ and CD8⁺ T lymphocytes in human toxoplasmosis. Mediat inflamm. 2014;2014:573825.</cite> [<a href="https://doi.org/10.1155/2014/573825" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4151596/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25214715/" class="usa-link">PubMed</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767–811.
</cite> [<a href="https://doi.org/10.1146/annurev.immunol.18.1.767" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10837075/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Banchereau%20J,%20Briere%20F,%20Caux%20C,%20et%20al.%20Immunobiology%20of%20dendritic%20cells.%20Annu%20Rev%20Immunol.%202000;18:767%E2%80%93811." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Aerts-Toegaert C, Heirman C, Tuyaerts S, et al. CD83 expression on dendritic cells and T cells: correlation with effective immune responses. Eur J Immunol. 2007;37(3):686–95.
</cite> [<a href="https://doi.org/10.1002/eji.200636535" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17301951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aerts-Toegaert%20C,%20Heirman%20C,%20Tuyaerts%20S,%20et%20al.%20CD83%20expression%20on%20dendritic%20cells%20and%20T%20cells:%20correlation%20with%20effective%20immune%20responses.%20Eur%20J%20Immunol.%202007;37(3):686%E2%80%9395." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Pinho MP, Migliori IK, Flatow EA, et al. Dendritic cell membrane CD83 enhances immune responses by boosting intracellular calcium release in T lymphocytes. J Leukoc Biol. 2014;95(5):755–62.
</cite> [<a href="https://doi.org/10.1189/jlb.0413239" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24436459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pinho%20MP,%20Migliori%20IK,%20Flatow%20EA,%20et%20al.%20Dendritic%20cell%20membrane%20CD83%20enhances%20immune%20responses%20by%20boosting%20intracellular%20calcium%20release%20in%20T%20lymphocytes.%20J%20Leukoc%20Biol.%202014;95(5):755%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Fooksman DR, Organizing. MHC class II presentation. Front Immunol. 2014;5:158.
</cite> [<a href="https://doi.org/10.3389/fimmu.2014.00158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3989578/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24782863/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fooksman%20DR,%20Organizing.%20MHC%20class%20II%20presentation.%20Front%20Immunol.%202014;5:158." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12374472/bin/12917_2025_4961_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (4.3MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12374472/bin/12917_2025_4961_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2</a><sup> (4.5MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12374472/bin/12917_2025_4961_MOESM3_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 3</a><sup> (595.7KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12374472/bin/12917_2025_4961_MOESM4_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 4</a><sup> (982KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12374472/bin/12917_2025_4961_MOESM5_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 5</a><sup> (182.2KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The raw data supporting the conclusions of this article will be made available by the corresponding author, without undue reservation.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from BMC Veterinary Research are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12917-025-04961-z"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12917_2025_Article_4961.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (7.3 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12374472/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12374472/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374472%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374472/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12374472/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12374472/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40849645/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12374472/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40849645/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12374472/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12374472/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="QlSHvDYTnlbZ1gUYky99RFrdsr4MDbQEfIMuya7yWJNeNp8nWGHHMTvchvVbt2eu">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
